a19058010.s4	Administration NN B-noun.person	of IN 0	green_tea NN B-noun.substance	( ( 0	100 CD 0	mg NN B-noun.quantity	/ ) 0	kg RB 0	/ JJ 0	day NN 0	, , 0	p.o RB 0	. . 0	) ) 0	. . 0
a9088814.s7	The DT 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	a DT 0	prolonged VBN B-verb.creation	combination NN B-noun.event	of IN 0	more JJR B-noun.quantity	than IN 0	120 CD 0	min NN 0	of IN 0	PGE1-induced JJ B-adj.all	hypotension NN B-noun.person	and CC 0	moderate JJ B-adj.all	haemodilution NN B-noun.person	would MD 0	cause VB B-verb.communication	impairment_of_hepatic_function NN B-noun.feeling	. . 0	. . 0
a12716030.s5	In IN 0	ICH NNP 0	induction NN 0	using VBG B-verb.consumption	0.014-unit JJ B-adj.all	collagenase NN B-noun.communication	, , 0	heparin NN B-noun.person	enhanced VBD B-verb.change	the DT 0	hematoma NN B-noun.attribute	volume NN I-noun.attribute	3.4-fold RB 0	over IN 0	that DT 0	seen VBN B-verb.perception	in IN 0	control NN B-noun.act	ICH NNP B-noun.group	animals NNS B-noun.food	and CC 0	the DT 0	bleeding VBG B-verb.contact	7.6-fold JJ I-verb.contact	. . 0	. . 0
a19356053.s9	In IN 0	21 CD B-adj.all	patients NNS B-noun.person	an DT 0	alternative JJ B-adj.all	cause NN B-noun.act	of IN 0	proteinuria NN B-noun.person	was VBD B-verb.stative	either DT 0	obvious JJ B-adj.all	or CC 0	insufficient JJ B-adj.all	data NNS B-noun.cognition	was VBD B-verb.stative	available JJ B-adj.all	to TO 0	be VB B-verb.stative	conclusive JJ B-adj.all	. . 0	. . 0
a15515654.s6	RESULTS NNS B-noun.artifact	, , 0	Overall NNP B-noun.person	, , 0	21 CD 0	out IN 0	of IN 0	104 CD 0	patients NNS B-noun.person	( ( 0	20.2 CD 0	% NN 0	) ) 0	presented VBN B-verb.perception	with IN 0	high JJ B-adj.all	frequency NN B-noun.quantity	sensorineural_hearing_loss NN 0	( ( 0	SNHL NNP 0	) ) 0	, , 0	either CC 0	unilateral JJ B-adj.all	or CC 0	bilateral JJ B-noun.possession	. . 0	. . 0
a17562951.s9	Mean JJ B-adj.all	post NN B-noun.act	- : 0	SCr NN B-noun.person	increases NNS B-noun.event	were VBD B-verb.stative	significantly RB B-adv.all	less RBR B-adv.all	with IN 0	iopamidol NN B-noun.person	( ( 0	all DT 0	patients NNS B-noun.person	, , 0	0.07 CD 0	versus NN 0	0.12 CD 0	mg PRP B-noun.quantity	/ : 0	dL PRP 0	, , 0	6.2 CD 0	versus CC 0	10.6 CD 0	micromol NN B-noun.quantity	/ '' 0	L NNP 0	, , 0	P=0.03 NNP B-noun.person	, , 0	patients NNS B-noun.person	with IN 0	diabetes NNS B-noun.person	, , 0	0.07 CD 0	versus CC 0	0.16 CD 0	mg PRP B-noun.quantity	/ : 0	dL PRP 0	, , 0	6.2 CD 0	versus CC 0	14.1 CD 0	micromol NNS B-noun.quantity	/ IN 0	L NNP B-noun.quantity	, , 0	P=0.01 NNP 0	) ) 0	. . 0	. . 0
a7919560.s7	Positive JJ B-adj.all	MIF NNP 0	test NN 0	for IN 0	ampicillin NN B-noun.person	showed VBD B-verb.communication	sensitization NN B-noun.person	of IN 0	the DT 0	patient NN B-noun.person	's POS 0	lymphocytes NNS B-noun.time	to TO 0	ampicillin VB B-verb.social	. . 0	. . 0
a2696505.s0	A DT 0	randomized JJ B-adj.all	comparison NN B-noun.person	of IN 0	labetalol NN B-noun.act	and CC 0	nitroprusside NN B-noun.person	for IN 0	induced JJ B-verb.creation	hypotension NN 0	. . 0	. . 0
a11334364.s4	For IN 0	the DT 0	cytoprotection NN B-noun.act	study NN B-noun.artifact	, , 0	animals NNS B-noun.person	were VBD 0	orally RB B-adv.all	gavaged VBD B-verb.creation	100 CD 0	mg NN B-noun.quantity	/ '' 0	Kg IN 0	GSPE NNP 0	for IN 0	7 CD 0	- : 0	10 CD B-adj.all	days NNS B-noun.time	followed VBN B-verb.stative	by IN 0	i.p NNP B-noun.person	. . 0	. . 0
a15130900.s9	The DT 0	absolute JJ B-adj.all	risk NN B-noun.person	for IN 0	bladder_cancer NN B-noun.person	in IN 0	the DT 0	cohort NN B-noun.person	reached VBD B-verb.contact	10 CD B-adj.all	% NN 0	16 CD B-adj.all	years NNS B-noun.time	after IN 0	diagnosis NN B-noun.person	of IN 0	Wegener's_granulomatosis NN B-noun.food	, , 0	and CC 0	a DT 0	history NN B-noun.cognition	of IN 0	bladder_cancer NN B-noun.person	was VBD B-verb.stative	( ( 0	non RB B-adv.all	- : 0	significantly RB B-adv.all	) ) 0	twice RB 0	as IN 0	common JJ 0	as IN 0	expected VBN B-verb.cognition	at IN 0	the DT 0	time NN B-noun.time	of IN 0	diagnosis NN B-noun.cognition	of IN 0	Wegener's_granulomatosis NN B-noun.food	. . 0	. . 0
a8638206.s0	Persistent JJ B-adj.all	paralysis NN B-noun.communication	after IN 0	prolonged VBN B-verb.social	use NN 0	of IN 0	atracurium NN B-noun.food	in IN 0	the DT 0	absence NN B-noun.act	of IN 0	corticosteroids NNS B-noun.food	. . 0	. . 0
a6466532.s7	should MD 0	immediately RB B-adv.all	precede VB B-verb.creation	induction NN B-noun.act	of IN 0	anaesthesia NN B-noun.animal	, , 0	in IN 0	children NNS B-noun.animal	, , 0	if IN 0	the DT 0	repeated VBN B-verb.communication	administration NN B-noun.person	of IN 0	suxamethonium NN B-noun.person	is VBZ 0	anticipated VBN B-verb.cognition	. . 0	. . 0
a9660111.s1	Trimipramine NNP B-noun.person	( ( 0	TRI NNP 0	) ) 0	, , 0	which WDT 0	shows VBZ B-verb.perception	a DT 0	clinical JJ B-adj.all	antidepressant JJ B-adj.all	activity NN B-noun.state	, , 0	is VBZ B-verb.stative	chemically RB B-adv.all	related VBN B-verb.cognition	to TO 0	imipramine VB B-verb.cognition	but CC 0	does VBZ 0	not RB B-adv.all	inhibit VB B-verb.change	the DT 0	reuptake NN B-noun.act	of IN 0	noradrenaline NN B-noun.person	and CC 0	5-hydroxytryptamine JJ 0	, , 0	nor CC 0	does VBZ 0	it PRP 0	induce VB B-verb.cognition	beta JJ 0	- : 0	adrenergic JJ 0	down IN 0	- : 0	regulation NN B-noun.act	. . 0	. . 0
a17439425.s2	Glucocorticoid SYM 0	- : 0	induced VBN B-verb.creation	hypertension NN 0	( ( 0	GC SYM 0	- : 0	HT NN 0	) ) 0	in IN 0	the DT 0	rat NN B-noun.person	is VBZ 0	associated VBN B-verb.cognition	with IN 0	nitric_oxide JJ B-noun.other	- : 0	redox NN B-noun.group	imbalance NN B-noun.person	. . 0	. . 0
a1867351.s1	This DT 0	study NN B-noun.communication	describes VBZ B-verb.creation	neuropsychiatric JJ B-adj.all	side NN B-noun.body	effects NNS B-noun.phenomenon	in IN 0	patients NNS B-noun.location	after IN 0	treatment NN B-noun.plant	with IN 0	mefloquine NN B-noun.person	. . 0	. . 0
a3101906.s6	The DT 0	average JJ B-adj.all	duration NN 0	of IN 0	treatment NN B-noun.plant	before IN 0	the DT 0	onset NN B-noun.event	of IN 0	jaundice NN B-noun.act	was VBD B-verb.stative	61 CD B-adj.all	days NNS B-noun.person	. . 0	. . 0
a1428568.s6	These DT 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	betaxolol NN B-noun.person	could MD 0	be VB B-verb.stative	less JJR B-noun.quantity	of IN 0	a DT 0	depression NN B-noun.person	- : 0	inducer NN B-noun.person	than IN 0	timolol NN 0	in IN 0	predisposed JJ B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a8410052.s2	Focal JJ B-adj.all	injury_in_the_cortex NN B-noun.act	was VBD 0	produced VBN B-verb.creation	by IN 0	infusion NN B-noun.cognition	of IN 0	lactate NN B-noun.person	at IN 0	acid NN B-noun.act	pH CD B-noun.attribute	or CC 0	by IN 0	stab NN B-noun.person	caused VBN B-verb.communication	by IN 0	needle JJ B-adj.all	insertion NN B-noun.person	. . 0	. . 0
a7504976.s10	Moreover RB B-adv.all	, , 0	hepatotoxicity NN 0	may MD 0	not RB 0	be VB 0	restricted VBN B-verb.social	to TO 0	one CD 0	class NN B-noun.attribute	of IN 0	antithyroid JJ B-adj.all	agents NNS B-noun.person	. . 0	. . 0
a9746003.s6	Optimal JJ B-adj.all	control NN B-noun.act	of IN 0	the DT 0	absences NNS B-noun.artifact	was VBD 0	achieved VBN B-verb.social	with IN 0	sodium_valproate JJ B-adj.all	, , 0	lamotrigine NN 0	, , 0	or CC 0	ethosuximide VB B-verb.stative	alone RB I-verb.stative	or CC 0	in IN 0	combination NN 0	. . 0	. . 0
a16740173.s3	METHODS NNS B-noun.attribute	, , 0	The DT 0	son NN 0	of IN 0	an DT 0	84-year JJ B-noun.group	- : 0	old JJ B-adj.all	male NN B-noun.person	discovered VBD B-verb.creation	a DT 0	newspaper NN B-noun.state	report NN I-noun.state	stating VBG B-verb.change	clinical JJ B-adj.all	success NN B-noun.person	with IN 0	plant NN B-noun.person	extracts NNS B-noun.person	in IN 0	Alzheimer's_disease NNP 0	. . 0	. . 0
a3856631.s2	The DT 0	methotrexate NN B-noun.person	was VBD 0	administered VBN B-verb.possession	as IN 0	a DT 0	loading NN B-noun.possession	dose NN B-noun.quantity	of IN 0	6,000 CD 0	mg PRP 0	/ : 0	m2 CC 0	for IN 0	a DT 0	period NN B-noun.time	of IN 0	one CD 0	hour NN 0	followed VBN B-verb.stative	by IN 0	an DT 0	infusion NN B-noun.cognition	of IN 0	1,200 CD 0	mg PRP 0	/ : 0	m2/h NN B-noun.food	for IN 0	23 CD B-adj.all	hours NNS B-noun.person	. . 0	. . 0
a8643971.s3	We PRP 0	initiated VBD B-verb.creation	a DT 0	phase NN B-noun.time	I PRP 0	/ VBP 0	II NNP 0	trial NN 0	to TO 0	determine VB B-verb.communication	the DT 0	response NN B-noun.communication	and CC 0	toxicity NN B-noun.attribute	of IN 0	escalating VBG B-verb.competition	paclitaxel NN B-noun.artifact	doses NNS B-noun.artifact	combined VBN B-verb.change	with IN 0	fixed VBN B-verb.consumption	- : 0	dose NN 0	cisplatin NN 0	with IN 0	granulocyte NN B-noun.person	colony NN B-noun.person	- : 0	stimulating JJ B-verb.communication	factor NN B-noun.person	support NN B-noun.person	in IN 0	patients NNS B-noun.person	with IN 0	untreated JJ B-adj.all	locally RB B-adv.all	advanced VBN B-verb.communication	inoperable JJ B-adj.all	head_and_neck_carcinoma NN B-noun.attribute	. . 0	. . 0
a10579464.s2	NRA0160 NN B-noun.artifact	is VBZ B-verb.stative	over IN 0	20,000fold RB B-adv.all	more RBR B-adv.all	potent JJ B-adj.all	at IN 0	the DT 0	dopamine NN B-noun.location	D4.2 JJ B-adj.all	receptor NN B-noun.person	compared VBN B-verb.change	with IN 0	the DT 0	human NN B-noun.person	cloned VBD B-verb.contact	dopamine NN B-noun.communication	D2L CD 0	receptor NN B-noun.person	. . 0	. . 0
a15338796.s18	DISCUSSION NN B-noun.artifact	, , 0	Quantifying VBG B-verb.communication	tremor NN I-verb.communication	by IN 0	using VBG B-verb.consumption	an DT 0	inexpensive JJ B-adj.all	laser NN B-adj.all	pointer NN B-noun.attribute	is VBZ B-verb.stative	, , 0	with IN 0	the DT 0	exception NN B-noun.act	of IN 0	children NNS B-noun.animal	( ( 0	< $ 0	12 CD B-adj.all	years NNS B-noun.time	) ) 0	a DT 0	sensitive JJ B-adj.all	and CC 0	reproducible JJ B-adj.all	method NN B-noun.attribute	. . 0	. . 0
a12921865.s8	These DT 0	findings NNS B-noun.act	demonstrate VBP B-verb.stative	that IN 0	some DT 0	neuroactive JJ B-adj.all	steroids NNS B-noun.communication	attenuate VBP B-verb.stative	convulsant JJ B-adj.all	and CC 0	sensitizing VBG B-verb.perception	properties NNS B-noun.attribute	of IN 0	cocaine NN B-noun.person	and CC 0	add VB B-verb.communication	to TO 0	a DT 0	growing VBG 0	literature NN B-noun.act	on IN 0	their PRP$ 0	potential JJ B-adj.all	use NN B-noun.person	in IN 0	the DT 0	modulation NN B-noun.time	of IN 0	effects NNS B-noun.phenomenon	of IN 0	drugs NNS B-noun.artifact	of IN 0	abuse NN B-noun.act	. . 0	. . 0
a18951540.s2	Ten CD 0	patients NNS B-noun.person	with IN 0	PD NNP 0	and CC 0	prominent JJ B-adj.all	dyskinesias NNS B-noun.person	had VBD B-verb.stative	rTMS NNS I-verb.stative	( ( 0	1,800 CD 0	pulses NNS B-noun.artifact	, , 0	1 CD 0	Hz NNP 0	rate NN B-noun.time	) ) 0	delivered VBN B-verb.stative	over IN 0	the DT 0	motor NN B-noun.person	cortex NN B-noun.person	for IN 0	4 CD B-adj.all	consecutive JJ B-adj.all	days NNS B-noun.phenomenon	twice RB 0	, , 0	once RB B-adv.all	real JJ B-adj.all	stimuli NNS B-noun.person	and CC 0	once RB B-adv.all	sham JJ B-adj.all	stimulation NN B-noun.artifact	were VBD 0	used VBN B-verb.consumption	, , 0	evaluations NNS B-noun.person	were VBD 0	done VBN B-verb.social	at IN 0	the DT 0	baseline NN B-noun.person	and CC 0	1 CD B-adj.all	day NN 0	after IN 0	the DT 0	end NN B-noun.time	of IN 0	each DT 0	of IN 0	the DT 0	treatment NN B-noun.communication	series NN B-noun.communication	. . 0	. . 0
a16167916.s1	BACKGROUND NN 0	, , 0	Markers NNP B-noun.person	of IN 0	fibrinolysis NN B-noun.food	, , 0	thrombin NN B-noun.person	- : 0	activatable JJ B-adj.all	fibrinolysis NN B-noun.person	inhibitor NN B-noun.person	( ( 0	TAFI NNP B-noun.group	) ) 0	, , 0	tissue NN B-noun.group	- : 0	type NN B-noun.person	plasminogen NN B-adj.all	activator NN B-noun.person	( ( 0	tPA NNP 0	) ) 0	, , 0	and CC 0	plasminogen NN B-noun.person	activator NN B-noun.person	inhibitor-1 JJ I-noun.person	( ( 0	PAI-1 NN 0	) ) 0	levels NNS B-noun.state	were VBD 0	studied VBN B-verb.cognition	for IN 0	the DT 0	evaluation NN B-noun.act	of IN 0	short JJ B-noun.body	- : 0	term NN B-noun.time	effects NNS B-noun.phenomenon	of IN 0	raloxifene NN B-noun.person	administration NN B-noun.person	in IN 0	postmenopausal JJ B-adj.all	women NNS B-noun.person	. . 0	. . 0
a17562951.s1	BACKGROUND NN 0	, , 0	No DT 0	direct JJ B-adj.all	comparisons NNS B-noun.relation	exist VBP B-verb.stative	of IN 0	the DT 0	renal JJ B-adj.all	tolerability NN B-noun.attribute	of IN 0	the DT 0	low JJ B-adj.all	- : 0	osmolality NN B-noun.attribute	contrast_medium NN 0	iopamidol NN 0	with IN 0	that DT 0	of IN 0	the DT 0	iso NN B-noun.person	- : 0	osmolality NN B-noun.attribute	contrast_medium NN 0	iodixanol NN B-noun.substance	in IN 0	high JJ B-adj.all	- : 0	risk NN 0	patients NNS B-noun.person	. . 0	. . 0
a12464714.s13	The DT 0	most RBS 0	common JJ B-noun.person	adverse JJ 0	events NNS 0	( ( 0	incidence NN B-noun.event	> : 0	or CC 0	= $ 0	5 CD B-adj.all	% NN 0	in IN 0	one CD 0	group NN 0	) ) 0	after IN 0	rizatriptan JJ B-noun.animal	and CC 0	ergotamine VB B-verb.change	/ : 0	caffeine NN B-noun.person	, , 0	respectively RB B-adv.all	, , 0	were VBD B-verb.stative	dizziness JJ B-adv.all	( ( 0	6.7 CD 0	and CC 0	5.3 CD 0	% NN 0	) ) 0	, , 0	nausea NN B-noun.person	( ( 0	4.2 CD 0	and CC 0	8.5 CD 0	% NN 0	) ) 0	and CC 0	somnolence NN 0	( ( 0	5.5 CD 0	and CC 0	2.3 CD 0	% NN 0	) ) 0	. . 0	. . 0
a18821488.s5	Health NNP B-noun.person	status NN B-noun.artifact	and CC 0	MHb NNP B-noun.person	levels NNS I-noun.person	were VBD 0	monitored VBN B-verb.perception	following JJ B-adj.all	exposure NN B-noun.communication	. . 0	. . 0
a1833784.s5	Nicotine NNP B-noun.person	( ( 0	1.0 CD 0	mg PRP 0	/ : 0	kg LS 0	) ) 0	caused VBD B-verb.creation	a DT 0	significant JJ B-adj.all	increase_in_locomotor_activity NN B-noun.attribute	in IN 0	rats NNS B-noun.animal	that WDT 0	were VBD 0	habituated VBN B-verb.social	to TO 0	the DT 0	test NN B-adj.all	environment NN B-noun.person	, , 0	but CC 0	had VBD 0	only RB B-adv.all	a DT 0	weak JJ B-noun.plant	and CC 0	delayed VBN B-verb.change	stimulant JJ B-adj.all	action NN B-noun.person	in IN 0	rats NNS B-noun.animal	that WDT 0	were VBD B-verb.stative	unfamiliar JJ B-adj.all	with IN 0	the DT 0	test NN B-adj.all	environment NN B-noun.person	. . 0	. . 0
a10091617.s2	Recently RB B-adv.all	, , 0	we PRP 0	found VBD B-verb.cognition	that DT 0	therapy NN B-noun.person	with IN 0	selegiline NN B-noun.person	and CC 0	L NNP 0	- : 0	dopa NN B-noun.person	was VBD 0	associated VBN B-verb.cognition	with IN 0	selective JJ B-adj.all	systolic_orthostatic_hypotension NN B-noun.act	which WDT 0	was VBD 0	abolished VBN B-verb.contact	by IN 0	withdrawal NN B-noun.person	of IN 0	selegiline NN B-noun.person	. . 0	. . 0
a15602202.s2	The DT 0	second JJ B-adj.all	episode NN B-noun.communication	was VBD B-verb.stative	more RBR B-adv.all	severe JJ 0	than IN 0	the DT 0	first JJ B-adj.all	, , 0	and CC 0	although IN 0	both DT 0	were VBD 0	treated VBN B-verb.change	with IN 0	intensive JJ B-adj.all	corticosteroid JJ B-adj.all	therapy NN B-noun.person	, , 0	renal JJ B-adj.all	function NN B-noun.attribute	remained VBD B-verb.change	impaired JJ I-verb.change	. . 0	. . 0
a17244258.s12	While IN 0	postjunctional JJ B-adj.all	beta NN B-noun.person	- : 0	adrenoceptor NN B-noun.person	- : 0	mediated VBD B-verb.communication	relaxations NNS B-noun.communication	are VBP 0	reduced VBN B-verb.change	, , 0	effects NNS B-noun.phenomenon	by IN 0	prejunctional JJ B-adj.all	inhibitory JJ B-adj.all	muscarinic JJ B-adj.pert	receptors NNS B-noun.person	may MD 0	be VB 0	increased VBN B-verb.change	. . 0	. . 0
a19657887.s8	Five CD 0	hours NNS 0	after IN 0	exposure NN B-noun.person	, , 0	he PRP 0	developed VBD B-verb.creation	disulfiram NN B-noun.person	- : 0	like IN 0	syndrome NN B-noun.person	with IN 0	flushing NN B-noun.person	, , 0	tachycardia NN B-noun.person	, , 0	and CC 0	arterial_hypotension NN B-noun.act	after IN 0	consuming VBG B-verb.motion	three CD 0	glasses NNS B-noun.quantity	of IN 0	wine NN B-noun.artifact	. . 0	. . 0
a1616457.s6	Differences NNS B-noun.person	in IN 0	the DT 0	parameters NNS B-noun.person	of IN 0	training NN B-verb.cognition	under IN 0	the DT 0	influence NN B-noun.cognition	of IN 0	pentobarbital JJ B-adj.all	between IN 0	Groups NNS B-noun.group	1 CD 0	and CC 0	2 CD B-adj.all	were VBD 0	revealed VBN B-verb.perception	. . 0	. . 0
a9245658.s2	Animal JJ B-adj.all	studies NNS B-noun.group	and CC 0	mechanistic JJ B-adj.all	studies NNS B-noun.group	indicate VBP B-verb.cognition	that IN 0	nicotine NN B-noun.person	could MD 0	play VB B-verb.creation	a DT 0	role NN B-noun.attribute	in IN 0	accelerating VBG B-verb.change	atherosclerosis NN B-noun.food	, , 0	but CC 0	evidence NN B-noun.event	among IN 0	humans NNS B-noun.person	is VBZ B-verb.stative	too RB B-adv.all	inadequate JJ B-adj.all	to TO 0	be VB B-verb.stative	definitive JJ B-adj.all	about IN 0	such PDT 0	an DT 0	effect NN B-noun.cognition	. . 0	. . 0
a8590259.s5	No DT 0	significant JJ B-adj.all	changes NNS B-noun.relation	in IN 0	diastolic JJ B-adj.all	blood NN B-noun.act	pressure NN B-noun.act	, , 0	pulse JJ B-adj.all	rate NN B-noun.time	and CC 0	basal NN B-adj.all	tear NN B-noun.body	secretion NN B-noun.act	were VBD 0	noted VBN B-verb.perception	. . 0	. . 0
a19767176.s5	Administration NN B-noun.person	of IN 0	50 CD B-adj.all	mg NN B-noun.quantity	/ ( 0	kg IN 0	PDTC NNP 0	( ( 0	low JJ B-adv.all	- : 0	dose NN B-noun.quantity	) ) 0	did VBD 0	not RB B-adv.all	exert VB B-verb.social	major JJ B-adj.all	effects NNS B-noun.phenomenon	on IN 0	the DT 0	development NN B-noun.process	of IN 0	a DT 0	status_epilepticus NN B-noun.state	or CC 0	the DT 0	mortality NN B-noun.attribute	rate NN B-noun.time	. . 0	. . 0
a1378968.s5	Consequently RB B-adv.all	, , 0	lithium NN B-noun.person	pretreatment NN B-noun.person	caused VBD B-verb.communication	a DT 0	fall NN B-noun.person	in IN 0	filtration NN 0	fraction NN B-noun.artifact	and CC 0	an DT 0	increase NN B-noun.act	in IN 0	fractional JJ B-adj.all	Li NNP 0	excretion NN 0	. . 0	. . 0
a12684739.s3	OBJECTIVES NNS B-noun.artifact	, , 0	Given VBN B-verb.possession	its PRP$ 0	preclinical JJ B-adj.all	success NN B-noun.state	for IN 0	treating VBG B-verb.change	substance_abuse NN B-noun.food	and CC 0	the DT 0	increased VBN B-verb.change	risk NN 0	of IN 0	visual_field_defects NNS B-noun.phenomenon	( ( 0	VFD NNP 0	) ) 0	associated VBN B-verb.cognition	with IN 0	cumulative JJ B-adj.all	lifetime NN B-noun.person	exposure NN B-noun.person	, , 0	we PRP 0	explored VBD B-verb.communication	the DT 0	effects NNS B-noun.phenomenon	of IN 0	sub SYM 0	- : 0	chronic JJ B-adj.all	low JJ B-adj.all	dose NN 0	GVG NNP 0	on IN 0	cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	increases NNS B-noun.event	in IN 0	nucleus JJ B-adj.all	accumbens NNS B-noun.person	( ( 0	NAcc NNP B-noun.person	) ) 0	dopamine NN 0	( ( 0	DA NNP 0	) ) 0	. . 0	. . 0
a8829025.s1	The DT 0	effect NN B-noun.cognition	of IN 0	nifedipine NN B-noun.person	on IN 0	renal JJ B-adj.all	function NN B-noun.act	in IN 0	liver NN B-noun.animal	transplant NN I-noun.animal	recipients NNS B-noun.person	who WP 0	were VBD 0	receiving VBG B-verb.communication	tacrolimus NN B-noun.person	was VBD 0	evaluated VBN B-verb.change	between IN 0	January NNP B-noun.person	1992 CD 0	and CC 0	January NNP B-noun.person	1996 CD 0	. . 0	. . 0
a8410052.s0	Immunohistochemical JJ B-adj.all	studies NNS B-noun.act	with IN 0	antibodies NNS B-noun.attribute	to TO 0	neurofilament JJ B-adj.all	proteins NNS B-noun.person	on IN 0	axonal_damage NN B-noun.food	in IN 0	experimental JJ B-adj.all	focal JJ B-adj.all	lesions NNS B-noun.person	in IN 0	rat NN 0	. . 0	. . 0
a322550.s5	Five CD 0	cm IN 0	H2O NNP B-noun.person	CPAP NNP I-noun.person	during IN 0	nitroprusside NN B-noun.person	did VBD 0	not RB B-adv.all	further RB B-adv.all	alter VB B-verb.change	any DT 0	of IN 0	the DT 0	above JJ 0	- : 0	mentioned VBN B-verb.cognition	variables NNS B-noun.cognition	. . 0	. . 0
a17439425.s10	5 CD B-adj.all	. . 0	. . 0
a2870085.s12	Use NNP B-noun.person	of IN 0	flestolol NN B-noun.person	in IN 0	the DT 0	critical JJ B-adj.all	care NN B-noun.animal	setting NN I-noun.animal	is VBZ B-verb.stative	currently RB B-adv.all	undergoing VBG B-verb.cognition	investigation NN B-noun.act	. . 0	. . 0
a19759529.s6	Results NNS B-noun.person	showed VBD B-verb.communication	that IN 0	SSR103800 NN 0	( ( 0	10 CD B-adj.all	- : 0	30 CD 0	mg FW 0	/ FW 0	kg FW 0	p.o FW 0	. . 0	) ) 0	. . 0
a19211690.s9	HS NNP 0	diet NN 0	for IN 0	4 CD B-adj.all	wk NN 0	caused VBD B-verb.communication	a DT 0	progressive JJ B-adj.all	increase NN B-noun.event	in IN 0	BP NNP 0	, , 0	protein NN B-noun.person	and CC 0	albumin NN B-noun.person	excretion NN B-noun.act	, , 0	and CC 0	glomerular_sclerosis NN B-noun.food	in IN 0	male NN 0	DS NNP 0	rats NNS B-noun.animal	, , 0	which WDT 0	were VBD 0	attenuated VBN B-verb.social	by IN 0	castration NN B-noun.person	. . 0	. . 0
a8864707.s11	Quantitative JJ B-adj.all	morphometric JJ B-adj.all	studies NNS B-noun.group	of IN 0	the DT 0	cerebellum NN B-noun.artifact	provide VBP B-verb.stative	valuable JJ B-adj.all	insights NNS B-noun.artifact	into IN 0	the DT 0	pathogenesis NN B-noun.location	of IN 0	cerebellar_disorders NNS B-noun.location	. . 0	. . 0
a8387218.s7	Most JJS 0	patients NNS B-noun.person	showed VBD B-verb.communication	improvement NN B-noun.state	in IN 0	individual JJ B-adj.all	parameters NNS B-noun.person	and CC 0	global JJ B-adj.all	score NN B-noun.group	of IN 0	quality NN B-noun.quantity	of IN 0	life NN B-noun.time	. . 0	. . 0
a1549199.s5	Nonpharmacologic JJ B-adj.all	concerns NNS B-noun.group	can MD 0	help VB B-verb.stative	the DT 0	Parkinson's_disease NN B-noun.location	patient NN B-noun.person	achieve NN B-noun.person	and CC 0	maintain VB B-verb.possession	optimal JJ B-adj.all	functioning NN B-noun.act	, , 0	including VBG B-verb.change	daily JJ B-adj.pert	exercise NN B-noun.act	, , 0	physical JJ B-adj.all	therapy NN B-noun.act	, , 0	and CC 0	involvement NN B-noun.person	with IN 0	support NN B-noun.food	groups NNS B-noun.group	. . 0	. . 0
a16403073.s2	We PRP 0	report VBP B-verb.communication	a DT 0	woman NN B-noun.person	with IN 0	coronary_artery_disease NN 0	who WP 0	developed VBD B-verb.creation	a DT 0	markedly RB B-adv.all	prolonged_QT_interval JJ B-adj.all	and CC 0	torsades_de_pointes NNP B-noun.person	( ( 0	TdP NNP 0	) ) 0	after IN 0	taking VBG B-verb.social	ketoconazole NN I-verb.social	for IN 0	treatment NN B-noun.act	of IN 0	fungal_infection NN B-noun.act	. . 0	. . 0
a11706060.s3	At IN 0	termination NN B-noun.act	of IN 0	the DT 0	experiments NNS B-noun.person	, , 0	mice NNS B-noun.animal	underwent JJ B-adj.all	echocardiography NN B-noun.person	, , 0	quantitation NN B-noun.quantity	of IN 0	abundance NN B-noun.act	of IN 0	molecular JJ B-adj.all	markers NNS B-noun.person	of IN 0	CM NNP B-noun.quantity	( ( 0	ventricular JJ B-adj.all	mRNA NNP B-noun.person	encoding VBG B-verb.social	atrial JJ B-adj.all	natriuretic JJ B-adj.all	factor NN B-noun.person	[ '' 0	ANF NNP B-noun.group	] : 0	and CC 0	sarcoplasmic JJ B-adj.all	calcium NN B-noun.person	ATPase NNP I-noun.person	[ POS 0	SERCA2 NN B-noun.group	] '' 0	) ) 0	, , 0	and CC 0	determination NN B-noun.cognition	of IN 0	plasma NN B-noun.substance	LA NNP 0	. . 0	. . 0
a10406016.s9	Acute NNP B-noun.person	white_matter_edema NNP I-noun.person	and CC 0	eventual JJ B-adj.pert	neuronal_loss NN B-noun.person	in IN 0	the DT 0	striatum NN B-noun.artifact	adjacent NN B-noun.artifact	to TO 0	the DT 0	hematoma NN B-noun.person	did VBD 0	not RB B-adv.all	differ VB B-verb.stative	between IN 0	the DT 0	two CD 0	groups NNS B-noun.group	. . 0	. . 0
a20080419.s5	Over IN 0	the DT 0	long JJ B-noun.body	- : 0	term NN B-noun.time	chronic NN 0	phase NN B-noun.time	( ( 0	120 CD 0	days NNS B-noun.phenomenon	after IN 0	transplantation NN B-noun.act	) ) 0	, , 0	only RB B-adv.all	25 CD B-adj.all	% NN 0	of IN 0	BMC NNP B-noun.group	- : 0	treated VBN B-verb.body	epileptic JJ B-adj.all	animals NNS B-noun.person	had VBD 0	seizures NNS B-noun.body	, , 0	but CC 0	with IN 0	a DT 0	lower JJR B-adj.all	frequency NN B-noun.person	and CC 0	duration NN 0	compared VBN 0	to TO 0	the DT 0	epileptic JJ B-adj.all	control NN B-noun.act	group NN I-noun.act	. . 0	. . 0
a11334364.s2	This DT 0	study NN B-noun.communication	assessed VBD B-verb.communication	the DT 0	ability NN B-noun.cognition	of IN 0	IH636_grape_seed_proanthocyanidin_extract NNP B-noun.location	( ( 0	GSPE NNP 0	) ) 0	to TO 0	prevent VB B-verb.social	acetaminophen NN B-noun.person	( ( 0	AAP)-induced JJ B-adj.all	nephrotoxicity NN B-noun.attribute	, , 0	amiodarone NN 0	( ( 0	AMI)-induced JJ B-noun.person	lung_toxicity NN I-noun.person	, , 0	and CC 0	doxorubicin NN B-noun.person	( ( 0	DOX)-induced JJ B-noun.artifact	cardiotoxicity NN I-noun.artifact	in IN 0	mice NNS B-noun.animal	. . 0	. . 0
a16755009.s4	Diazepam- NN B-noun.person	, , 0	scopolamine- NN B-noun.person	and CC 0	ageing VBG B-verb.communication	- : 0	induced VBN B-verb.creation	amnesia NN B-noun.person	served VBD B-verb.social	as IN 0	the DT 0	interoceptive JJ B-adj.all	behavioral NN B-noun.body	models NNS I-noun.body	. . 0	. . 0
a11807648.s1	BACKGROUND NN 0	, , 0	Fibrin NNP B-noun.person	sealants NNS I-noun.person	( ( 0	FS NNP 0	) ) 0	derived VBN B-verb.cognition	from IN 0	human JJ B-adj.all	plasma NN B-noun.person	are VBP 0	frequently RB B-adv.all	used VBN B-verb.consumption	in IN 0	neurosurgery NN B-noun.act	. . 0	. . 0
a3403780.s2	The DT 0	diagnostic JJ B-adj.all	difficulty NN B-noun.state	at IN 0	presentation NN B-noun.communication	is VBZ 0	highlighted VBN B-verb.change	. . 0	. . 0
a2425813.s2	In IN 0	the DT 0	liver NN B-noun.person	both DT 0	the DT 0	content NN B-noun.communication	of IN 0	RNA NNP B-noun.group	and CC 0	the DT 0	biosynthesis NN B-noun.cognition	of IN 0	ribosomal JJ B-adj.all	RNA NNP B-noun.group	increased VBD B-verb.change	while IN 0	both DT 0	the DT 0	RNA NNP B-noun.group	content NN B-noun.communication	and CC 0	ribosomal JJ B-adj.all	RNA NNP 0	biosynthesis NN 0	were VBD 0	reduced VBN B-verb.change	in IN 0	the DT 0	gastrocnemius NN B-noun.communication	muscle NN B-noun.communication	. . 0	. . 0
a17343925.s4	METHODS NNS B-noun.attribute	, , 0	This DT 0	study NN B-noun.artifact	was VBD 0	undertaken VBN B-verb.cognition	as IN 0	part NN 0	of IN 0	neonatal JJ B-adj.all	screening NN B-noun.act	for IN 0	hearing_impairment NN B-noun.state	and CC 0	involved VBN B-verb.stative	both DT 0	ears NNS B-noun.cognition	of IN 0	200 CD 0	newborns NNS B-noun.animal	. . 0	. . 0
a8864707.s4	In IN 0	addition NN 0	, , 0	we PRP 0	performed VBD B-verb.social	a DT 0	high JJ B-noun.group	- : 0	resolution NN B-noun.communication	3D CD 0	gradient NN B-noun.quantity	echo NN 0	, , 0	T1-weighted JJ B-adj.all	sequences NNS B-noun.artifact	at IN 0	a DT 0	1-mm JJ B-adj.all	slice NN B-noun.act	thickness NN I-noun.act	. . 0	. . 0
a10683478.s3	From IN 0	such JJ B-adj.all	experiments NNS B-noun.person	there EX 0	is VBZ B-verb.stative	evidence NN B-noun.attribute	that IN 0	characterization NN B-noun.act	and CC 0	detection NN B-noun.act	of IN 0	apomorphine NN B-noun.person	- : 0	induced JJ B-verb.creation	activity NN B-noun.process	in IN 0	rodents NNS B-noun.animal	critically RB B-adv.all	depends VBZ B-verb.cognition	upon IN I-verb.cognition	the DT 0	test NN B-adj.all	conditions NNS B-noun.cognition	employed VBN B-verb.consumption	. . 0	. . 0
a17244258.s0	In IN 0	vitro NN 0	characterization NN 0	of IN 0	parasympathetic JJ B-adj.all	and CC 0	sympathetic JJ B-adj.all	responses NNS B-noun.event	in IN 0	cyclophosphamide NN 0	- : 0	induced VBN B-verb.creation	cystitis NN B-noun.state	in IN 0	the DT 0	rat NN B-noun.artifact	. . 0	. . 0
a19759529.s4	Among IN 0	them PRP 0	are VBP B-verb.stative	glycine JJ B-adj.all	transporter-1 NN B-noun.artifact	( ( 0	GlyT1 NN 0	) ) 0	inhibitors NNS 0	such JJ 0	as IN 0	SSR103800 NN 0	, , 0	which WDT 0	indirectly RB B-adv.all	enhance VB B-verb.change	NMDA NNP B-noun.group	receptor NN B-noun.artifact	function NN B-noun.act	by IN 0	increasing VBG B-verb.change	the DT 0	glycine NN B-noun.person	( ( 0	a DT 0	co SYM 0	- : 0	agonist NN B-noun.person	for IN 0	the DT 0	NMDA NNP B-noun.group	receptor NN B-noun.artifact	) ) 0	levels NNS B-noun.state	in IN 0	the DT 0	synapse NN B-noun.act	. . 0	. . 0
a9100294.s0	Cardiovascular_alterations NNS B-noun.artifact	in IN 0	rat NN 0	fetuses NNS 0	exposed VBN B-verb.perception	to TO 0	calcium VB B-verb.communication	channel NN B-noun.animal	blockers NNS I-noun.animal	. . 0	. . 0
a17437408.s14	Furthermore RB B-adv.all	, , 0	our PRP$ 0	data NNS B-noun.cognition	suggest VBP B-verb.communication	that IN 0	TR(- LS 0	) ) 0	rats NNS B-noun.animal	are VBP B-verb.stative	an DT 0	interesting JJ B-adj.all	tool NN B-noun.act	to TO 0	study VB B-verb.cognition	consequences NNS B-noun.attribute	of IN 0	overexpression NN B-noun.act	of IN 0	Pgp NNP B-noun.person	in IN 0	the DT 0	BBB NNP B-noun.group	on IN 0	access NN 0	of IN 0	drugs NNS B-noun.artifact	in IN 0	the DT 0	brain NN B-noun.person	, , 0	without IN 0	the DT 0	need NN B-noun.object	of IN 0	inducing VBG B-verb.cognition	seizures NNS B-noun.act	or CC 0	other JJ 0	Pgp NNP B-noun.person	- : 0	enhancing VBG B-verb.communication	events NNS B-noun.person	for IN 0	this DT 0	purpose NN B-noun.attribute	. . 0	. . 0
a18560792.s4	METHODS NNS B-noun.attribute	, , 0	All DT 0	PD NNP B-noun.group	patients NNS B-noun.person	in IN 0	the DT 0	Amiens NNP B-noun.person	area NN 0	treated VBN B-verb.change	with IN 0	pergolide NN B-noun.person	were VBD 0	invited VBN B-verb.communication	to TO 0	attend VB B-verb.stative	a DT 0	cardiologic JJ B-adj.all	assessment NN B-noun.act	including VBG B-verb.change	transthoracic JJ B-adj.all	echocardiography NN B-noun.person	. . 0	. . 0
a8092427.s7	We PRP 0	selected VBD B-verb.cognition	the DT 0	54 CD 0	( ( 0	30.5 CD 0	% NN 0	) ) 0	cases NNS B-noun.quantity	of IN 0	immediate JJ B-adj.all	AX NNP 0	allergy NN 0	with IN 0	good JJ B-adj.all	tolerance NN B-noun.act	of IN 0	PG NNP 0	. . 0	. . 0
a3719553.s0	Allergic_reaction NN B-noun.act	to TO 0	5-fluorouracil JJ 0	infusion NN 0	. . 0	. . 0
a1009330.s2	The DT 0	results NNS B-noun.communication	have VBP 0	shown VBN B-verb.cognition	that IN 0	the DT 0	degradation NN B-noun.communication	product NN B-noun.cognition	p SYM 0	- : 0	choloroaniline NN B-noun.person	is VBZ B-verb.stative	not RB I-verb.stative	a DT 0	significant JJ B-adj.all	factor NN B-noun.person	in IN 0	chlorhexidine NN B-noun.act	- : 0	digluconate NN B-noun.person	associated VBN B-verb.cognition	erosive JJ B-adj.all	cystitis NN B-noun.state	. . 0	. . 0
a21029050.s4	METHODS NNS B-noun.attribute	, , 0	a DT 0	total NN B-noun.state	of IN 0	13 CD B-adj.all	patients NNS B-noun.person	were VBD 0	referred VBN B-verb.perception	to TO 0	the DT 0	Danish NNP B-noun.group	Cholinesterase NNP I-noun.group	Research NNP I-noun.group	Unit NNP I-noun.group	after IN 0	ECT NNP 0	during IN 0	38 CD 0	months NNS B-noun.person	. . 0	. . 0
a18631865.s2	Because IN 0	proteinuria NN B-noun.person	is VBZ B-verb.stative	a DT 0	major JJ B-adj.all	predictive JJ B-adj.all	factor NN B-noun.person	of IN 0	poor JJ B-adj.all	transplantation NN B-noun.event	outcome NN 0	, , 0	many JJ 0	studies NNS B-noun.person	focused VBD B-verb.social	on IN 0	this DT 0	adverse JJ B-adj.all	event NN 0	during IN 0	the DT 0	past JJ B-adj.all	years NNS B-noun.object	. . 0	. . 0
a21029050.s9	Severe JJ B-adj.all	distress NN B-noun.feeling	was VBD 0	noted VBN B-verb.perception	in IN 0	the DT 0	recovery NN B-noun.group	phase NN B-noun.time	in IN 0	two CD 0	patients NNS B-noun.person	. . 0	. . 0
a3371379.s1	Two CD 0	patients NNS B-noun.person	with IN 0	signs NNS B-noun.communication	of IN 0	carbamazepine NN B-noun.phenomenon	neurotoxicity NN B-noun.phenomenon	after IN 0	combined VBN B-verb.change	treatment NN I-verb.change	with IN 0	verapamil NN B-noun.person	showed VBD B-verb.communication	complete JJ B-adj.all	recovery NN B-noun.communication	after IN 0	discontinuation NN B-noun.act	of IN 0	the DT 0	calcium NN B-noun.artifact	entry NN B-noun.artifact	blocker NN B-noun.person	. . 0	. . 0
a11672959.s6	It PRP 0	is VBZ 0	thought VBN B-verb.cognition	that IN 0	the DT 0	clinico NN B-noun.person	- : 0	pathological JJ B-adj.all	features NNS B-noun.body	and CC 0	chronology NN B-noun.cognition	of IN 0	this DT 0	case NN B-noun.state	bore VBD B-verb.stative	the DT 0	hallmarks NNS B-noun.communication	of IN 0	the DT 0	so SYM 0	- : 0	called VBD B-verb.communication	" RP 0	3-week_sulphasalazine JJ B-adj.all	syndrome NN B-noun.artifact	" . 0	, , 0	a DT 0	rare JJ B-adj.all	, , 0	but CC 0	often RB B-adv.all	fatal JJ B-adj.all	, , 0	immunoallergic JJ B-adj.all	reaction NN B-noun.process	to_sulphasalazine NN B-noun.location	. . 0	. . 0
a12789195.s2	Significant JJ B-adj.all	disfiguring NN B-noun.artifact	changes NNS I-noun.artifact	occur VBP B-verb.stative	as IN 0	a DT 0	result NN B-noun.act	of IN 0	bone NN 0	, , 0	cartilage NN B-noun.communication	, , 0	and CC 0	soft JJ B-adj.all	tissue NN B-noun.substance	hypertrophy NN I-noun.substance	, , 0	including VBG B-verb.change	the DT 0	thickening NN 0	of IN 0	the DT 0	skin NN B-noun.artifact	, , 0	coarsening NN B-noun.person	of IN 0	facial JJ B-adj.all	features NNS B-noun.body	, , 0	and CC 0	cutis_verticis_gyrata NNP B-noun.cognition	. . 0	. . 0
a20520283.s3	With IN 0	last JJ B-adj.all	observations NNS B-noun.person	carried VBD B-verb.social	forward RB B-adv.all	( ( 0	LOCF NNP B-noun.group	) ) 0	, , 0	mean VBP B-verb.stative	Positive JJ B-noun.other	and CC I-noun.other	Negative NNP I-noun.other	Syndrome NNP I-noun.other	Scale NNP I-noun.other	total JJ B-adj.all	score NN B-noun.group	reductions NNS B-noun.person	from IN 0	baseline NN B-noun.person	to TO 0	endpoint VB B-verb.social	were VBD B-verb.stative	significantly RB B-adv.all	greater JJR B-adj.all	with IN 0	asenapine NN B-noun.person	at IN 0	5 CD 0	mg IN 0	BID NNP 0	( ( 0	-16.2 NNP 0	) ) 0	and CC 0	haloperidol NN B-noun.person	( ( 0	-15.4 NN 0	) ) 0	than IN 0	placebo NN 0	( ( 0	-10.7 UH 0	, , 0	both DT 0	P NNP 0	< $ 0	0.05 CD 0	) ) 0	, , 0	using VBG B-verb.consumption	mixed JJ B-adj.all	model NN B-noun.person	for IN 0	repeated VBN B-verb.communication	measures NNS B-noun.attribute	( ( 0	MMRM NNP B-noun.group	) ) 0	, , 0	changes NNS B-noun.phenomenon	at IN 0	day NN 0	42 CD 0	were VBD B-verb.stative	significantly RB B-adv.all	greater JJR B-adj.all	with IN 0	asenapine NN B-noun.person	at IN 0	5 CD B-adj.all	and CC 0	10 CD B-adj.all	mg IN 0	BID NNP 0	( ( 0	-21.3 JJ 0	and CC 0	-19.4 NNP B-noun.person	, , 0	respectively RB B-adv.all	) ) 0	and CC 0	haloperidol NN B-noun.person	( ( I-noun.person	-20.0 NNP I-noun.person	) ) 0	than IN 0	placebo NN 0	( ( 0	-14.6 UH 0	, , 0	all DT 0	P NNP 0	< $ 0	0.05 CD 0	) ) 0	. . 0	. . 0
a15145918.s6	SDRR NNP B-noun.group	was VBD 0	reduced VBN B-verb.change	only RB B-adv.all	by IN 0	alpha NN B-noun.person	- : 0	methyldopa NN B-noun.person	. . 0	. . 0
a18162529.s8	Lastly RB B-adv.all	, , 0	we PRP 0	measured VBD B-verb.cognition	PRL NNP B-noun.person	- : 0	R NN 0	and CC 0	suppressor NN 0	of IN 0	cytokine NN 0	signaling NN 0	( ( 0	SOCS-1 JJ B-noun.other	and CC 0	-3 : 0	and CC 0	CIS NNP 0	, , 0	which WDT 0	reflect VBP B-verb.possession	the DT 0	level NN B-noun.state	of IN 0	prolactin NN B-noun.substance	signaling NN B-noun.location	) ) 0	mRNAs NNS B-noun.other	in IN 0	response NN B-noun.communication	to TO 0	sulpiride VB 0	and CC 0	estradiol NN B-noun.act	. . 0	. . 0
a10526274.s19	This DT 0	age NN 0	group NN 0	had VBD 0	an DT 0	increased VBN B-verb.change	risk NN 0	of IN 0	myelosuppression NN B-noun.act	. . 0	. . 0
a6203452.s4	Because IN 0	each DT 0	patient NN B-noun.person	was VBD B-verb.stative	tumor NN B-noun.person	- : 0	free JJ B-verb.contact	or CC 0	had VBD 0	only RB B-adv.all	a DT 0	small JJ B-noun.person	tumor NN I-noun.person	at IN 0	the DT 0	onset NN B-noun.event	of IN 0	this DT 0	syndrome NN B-noun.cognition	, , 0	the DT 0	thrombotic_microangiopathy JJ 0	may MD 0	have VB 0	been VBN 0	induced VBN B-verb.creation	by IN 0	chemotherapy NN B-noun.communication	. . 0	. . 0
a2559236.s2	Rats NNS B-noun.person	were VBD 0	given VBN B-verb.possession	a DT 0	single JJ B-adj.all	dose NN B-noun.event	of IN 0	adriamycin NN B-noun.person	and CC 0	one CD 0	month NN 0	later RB B-adv.all	divided VBN B-verb.social	into IN 0	four CD 0	groups NNS B-noun.group	matched VBN B-verb.stative	for IN 0	albuminuria NNS B-noun.person	, , 0	blood NN B-noun.act	pressure NN B-noun.act	, , 0	and CC 0	plasma NN 0	albumin NN 0	concentration NN B-noun.cognition	. . 0	. . 0
a20067456.s10	The DT 0	ASEX NNP B-noun.group	score NN B-noun.group	and CC 0	CGI NNP B-noun.group	- : 0	SF NNP 0	score NN 0	were VBD B-verb.stative	correlated JJ B-adj.all	( ( 0	P= $ 0	0.003 CD 0	) ) 0	. . 0	. . 0
a8643971.s18	Paclitaxel NNP 0	/ ( 0	cisplatin NN B-noun.person	is VBZ B-verb.stative	an DT 0	effective JJ B-adj.all	first JJ B-noun.person	- : 0	line NN B-noun.person	regimen NNS B-noun.person	for IN 0	locoregionally RB B-adv.all	advanced VBD B-verb.communication	head_and_neck_cancer NN B-noun.person	and CC 0	continued VBD B-verb.stative	study NN B-noun.artifact	is VBZ 0	warranted VBN B-verb.communication	. . 0	. . 0
a11007689.s10	Patients NNS B-noun.person	who WP 0	are VBP 0	switched VBN B-verb.contact	from IN 0	cyclosporine NN B-noun.person	to TO 0	tacrolimus NN B-noun.state	or CC 0	vice NN B-noun.plant	versa NN B-noun.food	should MD 0	be VB B-verb.stative	closely RB B-adj.all	monitored VBN I-adj.all	for IN 0	the DT 0	signs NNS B-noun.communication	and CC 0	symptoms NNS B-noun.communication	of IN 0	recurrent NN B-noun.group	TMA NNP B-noun.group	. . 0	. . 0
a12523465.s8	Further JJ B-adj.all	observations NNS B-noun.motive	and CC 0	reports NNS B-noun.artifact	will MD 0	help VB 0	clarify VB B-verb.cognition	this DT 0	adverse JJ B-adj.all	effect NN B-noun.cognition	. . 0	. . 0
a18162529.s11	Interestingly RB B-adv.all	, , 0	estradiol NN 0	also RB B-adv.all	induced VBN B-verb.creation	PRL NNP B-noun.person	- : 0	R NN 0	, , 0	SOCS-3 NNP B-noun.other	, , 0	and CC 0	CIS NNP B-noun.person	mRNA NNP I-noun.person	levels NNS I-noun.person	independently RB B-adv.all	. . 0	. . 0
a10743446.s10	The DT 0	differential JJ B-adj.all	effects NNS B-noun.phenomenon	of IN 0	ketamine NN B-noun.person	and CC 0	lidocaine NN B-noun.person	on IN 0	static JJ B-adj.all	and CC 0	dynamic JJ B-adj.all	hyperalgesia NNS B-noun.person	suggest VBP B-verb.communication	that IN 0	the DT 0	two CD 0	types NNS B-noun.person	of IN 0	hyperalgesia NN 0	are VBP 0	mediated VBN B-verb.cognition	by IN 0	separate JJ B-adj.all	mechanisms NNS B-noun.person	and CC 0	have VBP B-verb.contact	a DT 0	distinct JJ B-adj.all	pharmacology NN B-noun.time	. . 0	. . 0
a17261653.s8	As IN 0	a DT 0	consequence NN B-noun.attribute	of IN 0	blocking VBG B-verb.change	I(f NNP 0	) ) 0	, , 0	clonidine NN B-noun.person	reduced VBD B-verb.change	the DT 0	slope NN B-noun.attribute	of IN 0	the DT 0	diastolic JJ B-adj.all	depolarization NN B-noun.act	and CC 0	the DT 0	frequency NN B-noun.person	of IN 0	pacemaker NN B-noun.person	potentials NNS B-noun.person	in IN 0	sinoatrial JJ B-adj.all	node NN B-noun.body	cells NNS B-noun.body	from IN 0	wild JJ B-noun.person	- : 0	type NN B-noun.person	and CC 0	alpha2ABC NNP B-noun.person	- : 0	knockout IN 0	mice NNS B-noun.person	. . 0	. . 0
a10526274.s8	RESULTS NNS B-noun.artifact	, , 0	One CD 0	hundred CD 0	sixty CD 0	- : 0	five CD B-adj.all	courses NNS B-noun.act	were VBD 0	administered VBN B-verb.perception	, , 0	with IN 0	a DT 0	median NN B-noun.communication	of IN 0	3 CD B-adj.all	. . 0	. . 0
a18560792.s0	Valvular_heart_disease NN B-noun.attribute	in IN 0	patients NNS B-noun.person	with IN 0	Parkinson's_disease NN B-noun.feeling	treated VBN B-verb.change	with IN 0	pergolide NN B-noun.person	. . 0	Course VB B-verb.cognition	following VBG 0	treatment NN B-noun.communication	modifications NNS B-noun.artifact	. . 0	. . 0
a88336.s8	It PRP 0	is VBZ 0	concluded VBN B-verb.cognition	that IN 0	when WRB 0	this DT 0	electroencephalographic JJ B-adj.all	and CC 0	behavioural JJ B-adj.all	picture NN B-noun.state	is VBZ 0	seen VBN B-verb.perception	in IN 0	drug NN 0	intoxication NN 0	, , 0	in IN 0	the DT 0	absence NN B-noun.act	of IN 0	significant JJ B-adj.all	hypoxaemia NN B-noun.person	, , 0	a DT 0	favourable JJ B-adj.all	outcome NN B-noun.person	may MD 0	be VB 0	anticipated VBN B-verb.cognition	. . 0	. . 0
a18821488.s6	RESULTS NNS B-noun.artifact	, , 0	The DT 0	selected VBN B-verb.cognition	doses NNS B-noun.quantity	of IN 0	WR242511 NN B-noun.food	, , 0	which WDT 0	produced VBD B-verb.creation	significant JJ B-adj.all	methemoglobinemia NN B-noun.attribute	in IN 0	beagle JJ B-adj.all	dogs NNS B-noun.person	in IN 0	earlier JJR B-adj.all	studies NNS B-noun.group	conducted VBN B-verb.social	elsewhere RB B-adv.all	, , 0	produced VBD B-verb.creation	very RB B-adv.all	little JJ B-adj.all	MHb NNP B-noun.person	( ( 0	mean VB B-verb.stative	< $ 0	2.0 CD B-noun.quantity	% NN 0	) ) 0	in IN 0	the DT 0	rhesus NN B-noun.body	monkey NN I-noun.body	. . 0	. . 0
a3076126.s1	Lovastatin NNP B-noun.person	and CC 0	simvastatin NN B-noun.act	are VBP B-verb.stative	the DT 0	2 CD B-adj.all	best JJS B-adj.all	- : 0	known VBN B-verb.cognition	members NNS B-noun.person	of IN 0	the DT 0	class NN B-noun.attribute	of IN 0	hypolipidaemic JJ B-adj.all	agents NNS B-noun.person	known VBN B-verb.cognition	as IN 0	HMG NNP B-noun.group	CoA MD 0	reductase VB B-verb.body	inhibitors NNS I-verb.body	. . 0	. . 0
a19058010.s5	and CC 0	vitamin VB B-verb.motion	E NNP 0	( ( 0	100 CD 0	mg NN B-noun.quantity	/ ) 0	kg RB 0	/ JJ 0	day NN 0	, , 0	p.o RB 0	. . 0	) ) 0	. . 0
a2265898.s3	Neither DT 0	patient NN B-noun.person	was VBD 0	considered VBN B-verb.cognition	to TO 0	have VB B-verb.social	a DT 0	renal JJ B-adj.all	state NN B-noun.location	sufficiently RB B-adv.all	severe JJ B-adj.all	enough NN B-noun.person	to TO 0	explain VB B-verb.consumption	their PRP$ 0	presentation NN B-noun.communication	. . 0	. . 0
a11135224.s15	CONCLUSIONS NNS B-noun.artifact	, , 0	The DT 0	combination NN B-noun.event	of IN 0	paclitaxel NN B-noun.artifact	, , 0	cisplatin NN B-noun.person	, , 0	and CC 0	gemcitabine NN B-noun.person	is VBZ B-verb.stative	well RB 0	tolerated VBN 0	and CC 0	shows VBZ B-verb.perception	high JJ B-adj.all	activity NN B-noun.process	in IN 0	metastatic JJ B-adj.all	NSCLC NNP B-noun.group	. . 0	. . 0
a19387625.s0	Attentional JJ B-adj.all	modulation NN B-noun.motive	of IN 0	perceived VBN B-verb.perception	pain NN I-verb.perception	intensity NN B-noun.attribute	in IN 0	capsaicin NN B-noun.act	- : 0	induced VBN B-verb.creation	secondary JJ B-adj.all	hyperalgesia NN B-noun.person	. . 0	. . 0
a983936.s8	Myocardial JJ B-adj.all	calcium NN B-noun.state	concentrations NNS I-noun.state	also RB B-adv.all	were VBD 0	decreased VBN B-verb.change	( ( 0	11.2 CD 0	, , 0	8.3 CD 0	, , 0	and CC 0	8.9 CD 0	mg NN B-noun.quantity	. . 0	. . 0
a3560096.s2	Several JJ B-adj.all	recent JJ B-adj.all	studies NNS B-noun.communication	have VBP 0	stressed VBN B-verb.communication	the DT 0	renal JJ B-adj.all	sparing NN B-noun.artifact	features NNS I-noun.artifact	of IN 0	sulindac NN B-noun.food	, , 0	owing VBG 0	to TO 0	its PRP$ 0	lack NN B-noun.state	of IN 0	interference NN B-noun.act	with IN 0	renal JJ B-adj.all	prostacyclin NN B-noun.person	synthesis NN B-noun.cognition	. . 0	. . 0
a3076126.s2	Clinical JJ B-adj.all	experience NN B-noun.event	with IN 0	lovastatin NN B-noun.feeling	includes VBZ B-verb.stative	over IN 0	5000 CD 0	patients NNS B-noun.person	, , 0	700 CD 0	of IN 0	whom WP 0	have VBP 0	been VBN 0	treated VBN B-verb.social	for IN 0	2 CD B-adj.all	years NNS B-noun.time	or CC 0	more JJR B-noun.quantity	, , 0	and CC 0	experience NN B-noun.person	with IN 0	simvastatin NN B-noun.person	includes VBZ B-verb.stative	over IN 0	3500 CD 0	patients NNS B-noun.person	, , 0	of IN 0	whom WP 0	350 CD 0	have VBP 0	been VBN 0	treated VBN B-verb.social	for IN 0	18 CD B-adj.all	months NNS B-noun.person	or CC 0	more JJR B-noun.quantity	. . 0	. . 0
a15009014.s0	Noxious JJ B-adj.all	chemical NN B-noun.communication	stimulation NN B-noun.cognition	of IN 0	rat JJ 0	facial JJ B-adj.all	mucosa NN B-noun.act	increases VBZ B-verb.change	intracranial JJ B-adj.all	blood NN B-noun.attribute	flow NN B-noun.process	through IN 0	a DT 0	trigemino NN B-noun.person	- : 0	parasympathetic JJ B-adj.all	reflex NN B-noun.person	-- : 0	an DT 0	experimental JJ B-adj.all	model NN B-noun.person	for IN 0	vascular_dysfunctions NNS B-noun.artifact	in IN 0	cluster_headache NNP 0	. . 0	. . 0
a19473225.s0	Long RB 0	- DT 0	term NN B-noun.time	glutamate NN 0	supplementation NN B-noun.person	failed VBD B-verb.social	to TO 0	protect VB B-verb.competition	against IN 0	peripheral_neurotoxicity NN B-noun.person	of IN 0	paclitaxel NN B-noun.artifact	. . 0	. . 0
a17343925.s1	OBJECTIVE NNP B-noun.group	, , 0	Maternal JJ 0	tobacco NN 0	smoking NN B-verb.consumption	has VBZ 0	negative JJ B-noun.phenomenon	effects NNS B-noun.phenomenon	on IN 0	fetal JJ B-adj.all	growth NN B-noun.process	. . 0	. . 0
a1720453.s7	Fifty JJ B-adj.all	- : 0	eight CD 0	patients NNS B-noun.person	( ( 0	78 CD 0	% NN 0	) ) 0	had VBD B-verb.stative	normal JJ B-adj.all	renal JJ B-noun.body	tests NNS I-noun.body	, , 0	whereas IN 0	16 CD B-adj.all	patients NNS B-noun.person	( ( 0	22 CD B-adj.all	% NN 0	) ) 0	had VBD 0	renal_abnormalities NNS B-noun.other	. . 0	. . 0
a347884.s9	Certain JJ B-adj.all	clues NNS B-noun.attribute	, , 0	including VBG B-verb.change	the DT 0	onset NN B-noun.event	of IN 0	action NN B-noun.person	, , 0	seem VBP 0	to TO 0	be VB B-verb.stative	indicative JJ B-adj.all	of IN 0	the DT 0	superiority NN B-noun.attribute	of IN 0	bromperidol NN B-noun.person	. . 0	. . 0
a7919560.s3	Medications NNS B-noun.person	were VBD 0	discontinued VBN B-verb.stative	when WRB 0	erythema_multiforme NN B-noun.person	and CC 0	congestive_heart_failure NN B-noun.act	caused VBN B-verb.communication	by IN 0	myocarditis NN B-noun.person	occurred VBD B-verb.cognition	. . 0	. . 0
a3173180.s0	Haemolytic JJ B-adj.all	- : 0	uraemic_syndrome NN 0	after IN 0	treatment NN B-noun.plant	with IN 0	metronidazole NN B-noun.attribute	. . 0	. . 0
a7265370.s0	Triamterene CD 0	nephrolithiasis NN 0	complicating VBG B-verb.stative	dyazide NN 0	therapy NN 0	. . 0	. . 0
a2572625.s1	We PRP 0	report VBP B-verb.communication	the DT 0	case NN B-noun.state	of IN 0	a DT 0	patient NN B-noun.person	who WP 0	developed VBD B-verb.creation	acute JJ B-adj.all	hepatitis NN 0	with IN 0	extensive_hepatocellular_necrosis NN B-noun.food	, , 0	7 CD B-adj.all	months NNS B-noun.person	after IN 0	the DT 0	onset NN B-noun.event	of IN 0	administration NN B-noun.time	of IN 0	clotiazepam NN B-noun.person	, , 0	a DT 0	thienodiazepine JJ 0	derivative NN 0	. . 0	. . 0
a17147461.s6	A DT 0	common JJ B-noun.person	risk NN I-noun.person	factor NN B-noun.person	appears VBZ B-verb.communication	to TO 0	be VB B-verb.stative	presence NN B-noun.person	of IN 0	pre SYM 0	- : 0	existing VBG B-verb.stative	chronic_renal_damage NN 0	. . 0	. . 0
a2870085.s1	Flestolol NNP B-noun.person	( ( 0	ACC-9089 NN 0	) ) 0	is VBZ B-verb.stative	a DT 0	nonselective JJ B-adj.all	, , 0	competitive JJ B-adj.all	, , 0	ultra JJ B-adj.all	- : 0	short JJ B-verb.communication	- : 0	acting VBG B-verb.social	beta NN I-verb.social	- : 0	adrenergic JJ B-adj.all	blocking VBG B-verb.change	agent NN B-noun.person	, , 0	without IN 0	any DT 0	intrinsic JJ B-adj.all	sympathomimetic JJ B-adj.all	activity NN B-noun.state	. . 0	. . 0
a18619688.s4	Neonatal JJ B-adj.all	cardiomyocytes NNS B-noun.group	were VBD 0	isolated VBN B-verb.change	from IN 0	Sprague NNP B-noun.person	- : 0	Dawley NNP B-noun.person	rat VBD B-verb.contact	hearts NNS B-noun.artifact	and CC 0	randomly RB B-adv.all	divided VBN B-verb.social	into IN 0	controls NNS B-noun.artifact	, , 0	an DT 0	adriamycin NN B-noun.person	- : 0	treated VBN B-verb.communication	group NN B-noun.person	, , 0	and CC 0	a DT 0	3MA NNP B-noun.person	plus CC 0	adriamycin NNS B-noun.person	- : 0	treated VBN B-verb.communication	group NN B-noun.person	. . 0	. . 0
a16274958.s0	Recurrent NN B-noun.person	dysphonia NN I-noun.person	and CC 0	acitretin NN B-noun.person	. . 0	. . 0
a8741744.s3	enhanced VBN B-verb.change	the DT 0	later RB B-adv.all	( ( 0	60 SYM 0	- : 0	120 CD 0	min NN 0	) ) 0	nicotine NN B-noun.person	- : 0	induced VBN B-verb.creation	hyperactivity NN B-noun.attribute	, , 0	and CC 0	raised VBD B-verb.communication	spontaneous JJ B-adj.all	nocturnal JJ B-adj.all	activity NN B-noun.process	. . 0	. . 0
a9754849.s0	Choreoathetoid_movements NNS B-noun.person	associated VBN B-verb.cognition	with IN 0	rapid JJ B-adj.all	adjustment NN B-noun.person	to TO 0	methadone NN B-noun.person	. . 0	. . 0
a16755009.s11	Daucus_carota_extract JJ B-adj.all	( ( 0	200 CD 0	, , 0	400 CD 0	mg NN B-noun.quantity	/ : 0	kg PRP 0	, , 0	p.o RB 0	. . 0	) ) 0	. . 0
a11334364.s3	Experimental JJ B-adj.all	design NN B-noun.artifact	consisted VBD B-verb.stative	of IN I-verb.stative	four CD B-adj.all	groups NNS B-noun.group	, , 0	control NN B-noun.act	( ( 0	vehicle NN B-noun.communication	alone RB 0	) ) 0	, , 0	GSPE NNP 0	alone RB 0	, , 0	drug NN 0	alone RB 0	and CC 0	GSPE+drug NN B-noun.person	. . 0	. . 0
a9351491.s7	Based VBN B-verb.cognition	on IN 0	these DT 0	observations NNS B-noun.act	, , 0	it PRP 0	is VBZ 0	concluded VBN B-verb.cognition	that IN 0	5-HT2 JJ B-adj.all	blockade NN B-noun.communication	obtained VBD B-verb.possession	with IN 0	risperidone NN 0	at IN 0	D2 JJ B-adj.all	occupancy NN B-noun.event	rates NNS B-noun.time	of IN 0	60 CD B-adj.all	% NN 0	and CC 0	above IN 0	does VBZ 0	not RB B-adv.all	appear VB B-verb.change	to TO 0	protect VB B-verb.competition	against IN 0	the DT 0	risk NN B-verb.social	for IN 0	extrapyramidal JJ B-adj.all	side NN B-noun.location	effects NNS B-noun.phenomenon	. . 0	. . 0
a8864707.s5	The DT 0	images NNS B-noun.artifact	were VBD 0	subsequently RB B-adv.all	processed VBN B-verb.social	to TO 0	obtain VB B-verb.possession	volumetric JJ B-adj.all	data NNS B-noun.cognition	for IN 0	the DT 0	cerebellum NN B-noun.artifact	. . 0	. . 0
a2266990.s0	Randomized VBN B-verb.cognition	, , 0	double RB 0	- : 0	blind JJ B-adj.all	trial NN B-noun.act	of IN 0	mazindol NN B-noun.person	in IN 0	Duchenne_dystrophy NN 0	. . 0	. . 0
a9862868.s3	Recently RB B-adv.all	, , 0	several JJ B-adj.all	TJ NNP 0	- : 0	associated JJ B-adj.all	proteins NNS B-noun.person	like IN 0	ZO-1 NN B-noun.person	and CC 0	7H6 CD 0	have VBP 0	been VBN 0	identified VBN B-verb.cognition	and CC 0	characterized VBD B-verb.communication	. . 0	. . 0
a12589964.s0	Evaluation NNP B-noun.person	of IN 0	cardiac JJ B-adj.all	troponin NN B-noun.person	I PRP 0	and CC 0	T NNP 0	levels NNS B-noun.attribute	as IN 0	markers NNS B-noun.person	of IN 0	myocardial_damage NN B-noun.food	in IN 0	doxorubicin NN B-noun.act	- : 0	induced VBN B-verb.creation	cardiomyopathy JJ B-adj.all	rats NNS B-noun.animal	, , 0	and CC 0	their PRP$ 0	relationship NN B-noun.state	with IN 0	echocardiographic JJ B-adj.all	and CC 0	histological JJ B-adj.all	findings NNS B-noun.act	. . 0	. . 0
a9522152.s2	The DT 0	surgery NN B-noun.artifact	and CC 0	anaesthesia NN B-noun.act	were VBD B-verb.stative	uneventful JJ B-adj.all	, , 0	but CC 0	3 CD B-adj.all	days NNS B-noun.phenomenon	after IN 0	surgery NN B-noun.location	, , 0	the DT 0	patient NN B-noun.person	reported VBD B-verb.communication	an DT 0	area NN B-noun.cognition	of IN 0	hypoaesthesia NN 0	over IN 0	L3-L4 JJ B-adj.all	dermatomes NNS B-noun.event	of IN 0	the DT 0	leg NN B-noun.communication	which WDT 0	had VBD 0	been VBN 0	operated VBN B-verb.contact	on IN 0	( ( 0	loss_of_pinprick_sensation NN B-noun.event	) ) 0	without IN 0	reduction NN B-noun.act	in IN 0	muscular JJ B-adj.all	strength NN B-noun.attribute	. . 0	. . 0
a7881871.s5	Kidney NNP B-noun.person	cortices NNS I-noun.person	from IN 0	each DT 0	animal NN 0	were VBD 0	used VBN B-verb.consumption	to TO 0	prepare VB B-verb.social	homogenates NNS B-noun.artifact	. . 0	. . 0
a20588063.s2	Using VBG B-verb.consumption	puromycin_aminonucleoside JJ 0	nephrosis NN B-noun.substance	( ( 0	PAN NNP 0	) ) 0	rats NNS B-noun.animal	, , 0	we PRP 0	studied VBD B-verb.cognition	early RB B-adv.all	ultrastructural JJ B-adj.all	and CC 0	permeability NN B-noun.possession	changes NNS I-noun.possession	in IN 0	relation NN 0	to TO 0	the DT 0	expression NN B-noun.communication	of IN 0	the DT 0	podocyte NN B-noun.person	- : 0	associated JJ B-adj.all	molecules NNS B-noun.body	nephrin NN I-noun.body	, , 0	a SYM 0	- : 0	actinin NN B-noun.person	, , 0	dendrin NN B-noun.person	, , 0	and CC 0	plekhh2 NN B-noun.person	, , 0	the DT 0	last JJ B-adj.all	two CD 0	of IN 0	which WDT 0	were VBD B-verb.stative	only RB B-adv.all	recently RB B-adv.all	discovered VBN B-verb.creation	in IN 0	podocytes NNS B-noun.location	. . 0	. . 0
a11587867.s4	Histological JJ B-adj.all	and CC 0	immunohistochemical JJ B-adj.all	investigations NNS B-noun.possession	( ( 0	HE PRP 0	- : 0	LFB NNP B-noun.group	, , 0	CD-68 NN B-noun.other	, , 0	Neurofilament NNP B-noun.person	) ) 0	revealed VBD B-verb.perception	degeneration_of_myelin_and_axons NNS B-noun.communication	as RB 0	well RB 0	as IN 0	pseudocystic_transformation NN 0	in IN 0	areas NNS B-noun.location	exposed VBN B-verb.communication	to TO 0	vincristine VB B-verb.social	, , 0	accompanied VBN B-verb.stative	by IN 0	secondary JJ B-adj.all	changes NNS B-noun.relation	with IN 0	numerous JJ B-adj.all	prominent JJ B-adj.all	macrophages NNS B-noun.person	. . 0	. . 0
a16005948.s2	Current JJ B-adj.all	protein NN B-noun.person	- : 0	based VBN B-verb.cognition	technology NN B-noun.attribute	offers VBZ B-verb.cognition	a DT 0	new JJ B-adj.all	therapeutic JJ B-adj.pert	venue NN B-noun.artifact	by IN 0	which WDT 0	antibodies NNS B-noun.person	bind VBP B-verb.social	the DT 0	drug NN B-noun.person	in IN 0	the DT 0	blood NN B-noun.body	stream NN I-noun.body	, , 0	inactivating VBG B-verb.communication	its PRP$ 0	toxic JJ B-adj.all	effects NNS B-noun.phenomenon	. . 0	. . 0
a10835440.s8	048 CD 0	) ) 0	. . 0	. . 0
a10365197.s6	These DT 0	findings NNS B-noun.act	suggest VBP B-verb.communication	some DT 0	validity NN B-noun.attribute	for IN 0	the DT 0	new JJ B-adj.all	DSM NNP B-noun.group	- : 0	IV NN 0	diagnosis NN 0	of IN 0	CIMD NNP B-noun.group	, , 0	but CC 0	also RB B-adv.all	suggest VBP B-verb.communication	that IN 0	it PRP 0	requires VBZ B-verb.stative	further JJ B-adj.all	specification NN B-noun.act	and CC 0	replication NN B-noun.act	. . 0	. . 0
a20003049.s8	This DT 0	is VBZ B-verb.stative	the DT 0	first JJ B-adj.all	report NN B-noun.communication	to TO 0	measure VB B-verb.change	plasma NN B-noun.substance	argatroban JJ B-noun.phenomenon	concentration NN I-noun.phenomenon	in IN 0	the DT 0	context NN B-noun.state	of IN 0	CPB NNP B-noun.group	and CC 0	extended VBN B-verb.consumption	coagulopathy NN I-verb.consumption	. . 0	. . 0
a10526274.s18	CONCLUSIONS NNS B-noun.artifact	, , 0	The DT 0	combination NN B-noun.event	of IN 0	GEM NNP B-noun.group	and CC 0	VNB NNP B-noun.group	is VBZ B-verb.stative	moderately RB B-adv.all	active JJ B-adj.all	and CC 0	well RB 0	tolerated VBN 0	except IN 0	in IN 0	patients NNS B-noun.person	age NN B-noun.person	> : 0	/= $ 0	75 CD 0	years NNS B-noun.time	. . 0	. . 0
a8919272.s6	Reduced NNP B-noun.person	size NN I-noun.person	of IN 0	capillary JJ B-adj.all	lumen NNS B-noun.person	and CC 0	occlusion NN B-noun.person	were VBD 0	caused VBN B-verb.communication	by IN 0	swollen JJ B-adj.all	endothelial JJ B-noun.body	cells NNS I-noun.body	which WDT 0	had VBD 0	luminal JJ B-adj.all	protrusions NNS B-noun.person	and CC 0	swollen VBN B-verb.contact	microvilli NNS B-noun.person	. . 0	. . 0
a2385256.s6	Her PRP$ 0	acetylcholine NN 0	receptor NN 0	antibody NN 0	level NN B-noun.state	was VBD B-verb.stative	markedly RB B-adv.all	elevated VBN B-verb.social	. . 0	. . 0
a3865016.s1	A DT 0	synergistic JJ B-adj.all	effect NN B-noun.cognition	of IN 0	etoposide NN 0	and CC 0	cyclosporin VB B-verb.consumption	A DT 0	was VBD 0	observed VBN B-verb.perception	in IN 0	a DT 0	patient NN B-noun.person	with IN 0	acute_T SYM 0	- : 0	lymphocytic_leukemia NN B-noun.person	in IN 0	relapse NN B-noun.act	. . 0	. . 0
a15325671.s2	In IN 0	high JJ B-adj.all	doses NNS B-noun.artifact	, , 0	its PRP$ 0	nonhematological JJ B-adj.all	dose NN B-noun.act	- : 0	limiting VBG B-verb.social	toxicity NN B-noun.attribute	is VBZ B-verb.stative	cardiomyopathy JJ B-adj.all	. . 0	. . 0
a9698967.s1	An DT 0	increase_in_blood_pressure NN B-noun.quantity	, , 0	accompanied VBN B-verb.stative	by IN 0	atrial_fibrillation NN B-noun.act	, , 0	agitation NN B-noun.person	, , 0	incomprehensible_shouts NNS B-noun.communication	and CC 0	loss_of_consciousness JJ B-noun.other	, , 0	was VBD 0	observed VBN B-verb.perception	in IN 0	an DT 0	elderly JJ B-adj.all	, , 0	ASA NNP 0	classification NN 0	group NN 0	II NNP 0	, , 0	cardiovascularly RB B-adv.all	medicated VBN B-verb.cognition	male NN B-noun.person	, , 0	12 CD B-adj.all	min NN B-noun.communication	after IN 0	performance NN B-noun.act	of IN 0	axillary JJ B-adj.all	block NN B-noun.person	with IN 0	mepivacaine NN B-noun.communication	850 CD 0	mg IN 0	containing VBG B-verb.stative	adrenaline JJ 0	0.225 CD 0	mg NN B-noun.quantity	, , 0	for IN 0	correction NN B-noun.communication	of IN 0	Dupuytren's_contracture NN B-noun.act	. . 0	. . 0
a7234705.s1	Seven CD 0	cases NNS B-noun.quantity	of IN 0	procainamide NN B-noun.person	- : 0	induced VBN B-verb.creation	polymorphous JJ B-adj.all	ventricular_tachycardia NNS B-noun.location	are VBP 0	presented VBN B-verb.perception	. . 0	. . 0
a6640832.s4	The DT 0	tolerance NN B-noun.act	was VBD 0	evaluated VBN B-verb.change	in IN 0	these DT 0	110 CD 0	patients NNS B-noun.person	, , 0	and CC 0	29 CD B-adj.all	patients NNS B-noun.person	presented VBD B-verb.communication	with IN 0	local JJ B-adj.all	side NN B-noun.group	- : 0	effects NNS B-noun.phenomenon	. . 0	. . 0
a16787750.s3	The DT 0	typical JJ B-adj.all	signs NNS B-noun.communication	of IN 0	VPA NNP B-noun.group	- : 0	induced VBN B-verb.creation	encephalopathy JJ B-adj.all	are VBP B-verb.stative	impaired_consciousness JJ B-adj.all	, , 0	sometimes RB B-adv.all	marked VBN B-verb.cognition	EEG NNP 0	background NN 0	slowing NN B-verb.change	, , 0	increased VBD B-verb.change	seizure NN B-noun.act	frequency NN B-noun.person	, , 0	with IN 0	or CC 0	without IN 0	hyperammonemia NN B-noun.time	. . 0	. . 0
a10835440.s12	CONCLUSIONS NNS B-noun.artifact	, , 0	DBP NNP 0	, , 0	but CC 0	not RB 0	SBP NNP 0	, , 0	reduction NN B-noun.person	was VBD 0	associated VBN B-verb.cognition	with IN 0	neurological JJ B-adj.all	worsening VBG B-verb.body	after IN 0	the DT 0	intravenous JJ B-adj.all	administration NN B-noun.time	of IN 0	high JJ B-noun.group	- : 0	dose NN B-noun.communication	nimodipine NN I-noun.communication	after IN 0	acute_stroke NNP B-noun.person	. . 0	. . 0
a15130900.s8	Treatment NN 0	duration NN 0	longer RBR 0	than IN 0	1 CD B-adj.all	year NN B-noun.time	was VBD 0	associated VBN B-verb.cognition	with IN 0	an DT 0	eightfold JJ B-adj.all	increased VBN B-verb.change	risk NN 0	( ( 0	OR CC 0	= SYM 0	7.7 CD 0	, , 0	95 CD 0	% NN 0	CI $ 0	0.9 CD 0	to TO 0	69 CD 0	) ) 0	. . 0	. . 0
a1833784.s10	The DT 0	effect NN B-noun.communication	appears VBZ B-verb.stative	to TO 0	be VB 0	mediated VBN B-verb.cognition	by IN 0	central JJ B-adj.pert	nicotine JJ B-noun.person	receptors NNS B-noun.person	, , 0	possibly RB 0	located VBN 0	on IN 0	dopaminergic JJ B-adj.all	neurons NNS B-noun.person	, , 0	and CC 0	also RB B-adv.all	requires VBZ B-verb.stative	the DT 0	activation NN B-noun.act	of IN 0	both DT 0	D1 : 0	and CC 0	D2 : 0	dopamine NN B-noun.person	receptors NNS B-noun.person	. . 0	. . 0
a12198388.s12	CONCLUSIONS NNS B-noun.artifact	, , 0	These DT 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	differences NNS B-noun.state	in IN 0	cholinergic JJ B-adj.all	activity NN B-noun.state	and CC 0	postsynaptic JJ B-adj.all	sensitivity NN B-noun.feeling	to TO 0	cholinergic JJ B-adj.all	convulsants NNS B-noun.group	may MD 0	be VB 0	associated VBN B-verb.cognition	with IN 0	ethanol NN 0	withdrawal NN 0	severity NN 0	and CC 0	implicate VB B-verb.change	cholinergic JJ B-adj.all	mechanisms NNS B-noun.person	in IN 0	alcohol NN 0	withdrawal NN 0	. . 0	. . 0
a15338796.s7	The DT 0	circle NN B-noun.act	in IN 0	which WDT 0	the DT 0	participant NN B-noun.person	succeeded VBD B-verb.social	to TO 0	aim VB B-verb.social	was VBD 0	recorded VBN B-verb.communication	in IN 0	millimetres NNS B-noun.body	radius NN I-noun.body	. . 0	. . 0
a4027862.s2	Delirium NNP B-noun.person	, , 0	which WDT 0	may MD 0	be VB 0	induced VBN B-verb.creation	by IN 0	tricyclic JJ B-adj.all	drug NN B-noun.person	therapy NN 0	in IN 0	the DT 0	elderly JJ B-adj.all	, , 0	can MD 0	be VB 0	caused VBN B-verb.communication	by IN 0	tricyclics NNS B-noun.person	with IN 0	low JJ B-adj.all	anticholinergic JJ B-adj.all	potency NN B-noun.person	. . 0	. . 0
a12584269.s3	In IN 0	a DT 0	number NN B-noun.quantity	of IN 0	treatment NN B-noun.plant	protocols NNS B-noun.artifact	where WRB 0	SRL NNP 0	was VBD 0	combined VBN B-verb.change	with IN 0	a DT 0	calcineurin NN B-noun.person	inhibitor NN B-noun.person	indications NNS I-noun.person	of IN 0	a DT 0	synergistic JJ B-adj.all	nephrotoxic JJ B-adj.all	effect NN B-noun.phenomenon	were VBD 0	described VBN B-verb.communication	. . 0	. . 0
a1616457.s7	These DT 0	findings NNS B-noun.act	show VBP B-verb.communication	that IN 0	the DT 0	brain NN B-noun.person	- : 0	dissociated VBN B-verb.cognition	state NN B-noun.state	induced VBN B-verb.creation	by IN 0	pentobarbital NN B-noun.person	is VBZ 0	formed VBN B-verb.stative	with IN 0	the DT 0	participation NN B-noun.act	of IN 0	the DT 0	mechanisms NNS B-noun.person	of IN 0	information NN B-noun.cognition	perception NN B-noun.person	. . 0	. . 0
a7234705.s4	These DT 0	patients NNS B-noun.person	had VBD 0	Q NNP 0	- : 0	T_prolongation NN B-noun.act	and CC 0	recurrent NN B-noun.act	syncope NN 0	due JJ 0	to TO 0	polymorphous JJ B-adj.all	ventricular_tachycardia NNS B-noun.location	. . 0	. . 0
a18023325.s10	Laryngoscopy NNP B-noun.person	revealed VBD B-verb.perception	asymmetric JJ B-adj.all	vocal JJ B-adj.all	fold JJ B-adj.all	movements NNS B-noun.artifact	during IN 0	phonation NN B-noun.artifact	. . 0	. . 0
a12198388.s9	In IN 0	microdialysis NN B-noun.animal	experiments NNS B-noun.person	, , 0	the DT 0	lines NNS B-noun.group	did VBD 0	not RB B-adv.all	differ VB B-verb.stative	in IN 0	basal NN B-adj.all	release NN B-noun.state	of IN 0	ACh NNP B-noun.person	, , 0	and CC 0	50 CD B-adj.all	mM CD B-noun.quantity	KCl NNP B-noun.person	increased VBD B-verb.change	ACh NNP 0	output NN 0	in IN 0	both DT 0	lines NNS B-noun.group	of IN 0	mice NNS B-noun.animal	. . 0	. . 0
a8170551.s5	Renal JJ B-adj.all	function NN B-noun.act	remained VBD B-verb.stative	normal JJ B-adj.all	in IN 0	all DT 0	patients NNS B-noun.person	. . 0	. . 0
a16867021.s2	The DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	designed VBN B-verb.creation	to TO 0	study VB B-verb.cognition	the DT 0	effect NN B-noun.cognition	of IN 0	histamine NN B-noun.location	H(3)-receptor NN B-noun.person	ligands VBZ B-verb.social	on IN 0	neuroleptic JJ B-adj.all	- : 0	induced VBN B-verb.creation	catalepsy NN B-noun.artifact	, , 0	apomorphine JJ B-noun.person	- : 0	induced VBN B-verb.creation	climbing VBG B-verb.motion	behavior NN B-noun.attribute	and CC 0	amphetamine JJ B-noun.person	- : 0	induced VBN B-verb.creation	locomotor NN B-noun.feeling	activities NNS B-noun.person	in IN 0	mice NNS B-noun.animal	. . 0	. . 0
a3101906.s7	None NN 0	of IN 0	these DT 0	well RB 0	validated VBN B-verb.social	cases NNS B-noun.person	occurred VBD B-verb.stative	within IN 0	the DT 0	first JJ B-verb.competition	10 CD B-adj.all	days NNS B-noun.time	after IN 0	treatment NN B-noun.plant	. . 0	. . 0
a18020536.s14	However RB 0	, , 0	use NN 0	of IN 0	BZDs NNP B-noun.group	/ NNP I-noun.group	RDs NNP I-noun.group	was VBD 0	associated VBN B-verb.cognition	with IN 0	dizziness NN B-noun.feeling	, , 0	inability_to_sleep JJ B-adj.all	after IN 0	awaking VBG B-verb.competition	at IN 0	night NN B-noun.artifact	and CC 0	tiredness NN B-noun.state	in IN 0	the DT 0	mornings NNS B-noun.artifact	during IN 0	the DT 0	week NN B-noun.time	prior RB 0	to TO 0	admission NN B-noun.person	and CC 0	with IN 0	stronger JJR B-adj.all	depressive_symptoms NNS B-noun.person	measured VBN B-verb.cognition	at IN 0	the DT 0	beginning NN B-noun.cognition	of IN 0	the DT 0	hospital NN B-noun.artifact	stay NN B-noun.artifact	. . 0	. . 0
a16858720.s9	CONCLUSIONS NNS B-noun.artifact	, , 0	Warfarin NNP B-noun.person	- : 0	induced VBN B-verb.creation	cerebral_haemorrhages NNS B-noun.artifact	are VBP B-verb.stative	a DT 0	major JJ B-adj.all	clinical JJ B-adj.pert	problem NN B-noun.communication	with IN 0	a DT 0	high JJ B-adj.all	fatality NN B-noun.attribute	rate NN B-noun.time	. . 0	. . 0
a17111419.s11	Laboratory NN B-noun.possession	measurement NN B-noun.attribute	of IN 0	pre SYM 0	- : 0	procedure NN B-noun.act	serum NN B-noun.artifact	calcium NN I-noun.artifact	levels NNS B-noun.attribute	in IN 0	selected VBN B-verb.cognition	donors NNS B-noun.person	may MD 0	identify VB B-verb.cognition	cases NNS B-noun.person	requiring VBG B-verb.communication	heightened VBN B-verb.consumption	vigilance NN I-verb.consumption	. . 0	. . 0
a1664218.s8	Further JJ B-adj.all	testing NN B-verb.communication	in IN 0	this DT 0	and CC 0	other JJ 0	tumour NN 0	types NNS B-noun.person	using VBG B-verb.consumption	multiple JJ B-adj.all	daily JJ B-adj.pert	schedules NNS B-noun.person	is VBZ 0	warranted VBN B-verb.communication	. . 0	. . 0
a2304736.s7	Patients NNS B-noun.person	who WP 0	present VBP B-verb.stative	with IN 0	stress_incontinence NN B-noun.attribute	while IN 0	taking VBG 0	prazosin NN B-noun.substance	should MD 0	change VB B-verb.motion	their PRP$ 0	antihypertensive JJ B-adj.all	medication NN B-noun.artifact	before IN 0	considering VBG B-verb.possession	surgery NN B-noun.communication	, , 0	because IN 0	their PRP$ 0	incontinence NN B-noun.possession	may MD 0	resolve VB B-verb.cognition	spontaneously RB B-adv.all	with IN 0	a DT 0	change NN B-noun.act	in IN 0	drug NN 0	therapy NN 0	. . 0	. . 0
a3780846.s6	The DT 0	rigidity NN B-noun.attribute	was VBD B-verb.stative	considerably RB B-adv.all	decreased VBN B-verb.change	in IN 0	both DT 0	groups NNS B-noun.group	after IN 0	20 CD B-adj.all	days NNS B-noun.person	' POS 0	treatment NN B-noun.communication	. . 0	. . 0
a2476560.s1	Treatment NN B-noun.person	for IN 0	scabies NNS B-noun.relation	is VBZ B-verb.stative	usually RB B-adv.all	initiated VBN B-verb.cognition	by IN 0	general JJ B-adj.all	practitioners NNS B-noun.person	, , 0	most JJS 0	consider VBP B-verb.communication	lindane NN B-noun.person	( ( 0	gamma_benzene_hexachloride NN 0	) ) 0	the DT 0	treatment NN B-noun.communication	of IN 0	choice NN B-noun.act	. . 0	. . 0
a19884587.s8	Other JJ 0	antibacterial JJ B-adj.all	agents NNS B-noun.person	that WDT 0	showed VBD B-verb.communication	associations NNS B-noun.person	included VBD B-verb.stative	erythromycins NNS B-noun.person	( ( 0	2 CD B-adj.all	defects NNS B-noun.act	) ) 0	, , 0	penicillins NNS B-noun.person	( ( 0	1 CD B-adj.all	defect NN B-noun.event	) ) 0	, , 0	cephalosporins NNS B-noun.person	( ( 0	1 CD B-adj.all	defect NN B-noun.event	) ) 0	, , 0	and CC 0	quinolones NNS B-noun.communication	( ( 0	1 CD B-adj.all	defect NN B-noun.event	) ) 0	. . 0	. . 0
a19767176.s2	Both DT 0	, , 0	production NN B-noun.person	of IN 0	reactive JJ B-adj.all	oxygen NN B-noun.animal	species NNS I-noun.animal	as RB 0	well RB 0	as IN 0	activation NN B-noun.person	of IN 0	NF NNP 0	- : 0	kappaB WDT 0	have VBP 0	been VBN 0	implicated VBN B-verb.communication	in IN 0	severe JJ B-adj.all	neuronal_damage NN B-noun.act	in IN 0	different JJ B-adj.all	sub NN B-noun.person	- : 0	regions NNS B-noun.act	of IN 0	the DT 0	hippocampus NN 0	as RB 0	well RB 0	as IN 0	in IN 0	the DT 0	surrounding VBG B-adj.all	cortices NNS B-noun.artifact	. . 0	. . 0
a20067456.s9	The DT 0	EDITS NNS B-noun.group	scores NNS B-noun.person	were VBD B-verb.stative	67.4 CD 0	( ( 0	10.2 CD 0	) ) 0	for IN 0	the DT 0	bupropion NN B-noun.artifact	and CC 0	36.3 CD 0	( ( 0	11.7 CD 0	) ) 0	for IN 0	the DT 0	placebo NN B-noun.location	group NN 0	( ( 0	P= $ 0	0.001 CD 0	) ) 0	. . 0	. . 0
a10721819.s1	It PRP 0	has VBZ 0	been VBN 0	shown VBN B-verb.cognition	that IN 0	bromocriptine NN B-noun.person	- : 0	induced VBN B-verb.creation	tachycardia NN B-noun.person	, , 0	which WDT 0	persisted VBD B-verb.communication	after IN 0	adrenalectomy NN B-noun.person	, , 0	is VBZ B-verb.stative	( ( 0	i NN 0	) ) 0	mediated VBN B-verb.stative	by IN 0	central JJ B-adj.pert	dopamine NN B-noun.group	D2 : 0	receptor NN B-noun.person	activation NN B-noun.person	and CC 0	( ( 0	ii NN 0	) ) 0	reduced VBN B-verb.change	by IN 0	5-day JJ B-adj.all	isoproterenol NN B-noun.substance	pretreatment NN I-noun.substance	, , 0	supporting VBG B-verb.cognition	therefore RB 0	the DT 0	hypothesis NN B-noun.cognition	that IN 0	this DT 0	effect NN B-noun.cognition	is VBZ B-verb.stative	dependent JJ B-adj.all	on IN 0	sympathetic JJ B-adj.all	outflow NN B-noun.event	to TO 0	the DT 0	heart NN B-noun.body	. . 0	. . 0
a10835440.s11	There EX 0	was VBD B-verb.stative	no DT 0	correlation NN B-noun.cognition	between IN 0	SBP NNP 0	change NN B-noun.artifact	and CC 0	outcome NN B-noun.person	. . 0	. . 0
a1833784.s0	Evidence NN B-noun.person	for IN 0	an DT 0	involvement NN B-noun.person	of IN 0	D1 : 0	and CC 0	D2 : 0	dopamine NN B-noun.person	receptors NNS B-noun.person	in IN 0	mediating VBG B-verb.communication	nicotine NN B-noun.person	- : 0	induced VBN B-verb.creation	hyperactivity NN B-noun.attribute	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a8752018.s1	BACKGROUND NN 0	, , 0	Lithium NNP B-noun.person	remains VBZ B-verb.stative	a DT 0	first JJ B-noun.person	- : 0	line NN B-noun.communication	treatment NN B-noun.communication	for IN 0	the DT 0	acute NN B-noun.person	and CC 0	maintenance NN B-noun.communication	treatment NN B-noun.communication	of IN 0	bipolar_disorder NN B-noun.other	. . 0	. . 0
a3615541.s1	Calcitonin NN B-noun.person	receptors NNS I-noun.person	are VBP 0	found VBN B-verb.possession	in IN 0	the DT 0	brain NN B-noun.person	, , 0	and CC 0	intracerebral JJ B-adj.all	infusions NNS B-noun.cognition	of IN 0	calcitonin NN B-noun.communication	can MD 0	produce VB B-verb.change	behavioral JJ B-adj.all	effects NNS B-noun.phenomenon	. . 0	. . 0
a3409645.s5	Depressed_mood NN B-noun.possession	was VBD B-verb.stative	more JJR B-adv.all	common JJ B-adj.all	among IN 0	patients NNS B-noun.person	and CC 0	was VBD 0	associated VBN B-verb.cognition	with IN 0	certain JJ B-adj.all	sexual JJ B-adj.all	difficulties NNS B-noun.state	, , 0	but CC 0	not RB B-adv.all	with IN 0	impotence NN B-noun.feeling	. . 0	. . 0
a1967484.s3	We PRP 0	studied VBD B-verb.cognition	a DT 0	37-year JJ 0	- : 0	old JJ B-adj.all	man NN B-noun.person	who WP 0	developed VBD B-verb.creation	persistent JJ B-adj.all	segmental JJ B-adj.all	dystonia NN B-noun.location	within IN 0	2 CD B-adj.all	months NNS B-noun.person	after IN 0	starting VBG B-verb.change	sulpiride NN 0	therapy NN 0	. . 0	. . 0
a3425586.s2	Her PRP$ 0	red JJ B-adj.all	blood NN B-noun.body	cells NNS I-noun.body	( ( 0	RBCs NNP B-noun.person	) ) 0	had VBD 0	increased VBN B-verb.change	incubated VBN B-verb.stative	Heinz NNP 0	body NN 0	formation NN B-noun.act	, , 0	decreased VBD B-verb.communication	reduced VBN B-verb.change	glutathione NN 0	( ( 0	GSH NNP 0	) ) 0	, , 0	and CC 0	decreased VBD B-verb.change	GSH NNP 0	stability NN 0	. . 0	. . 0
a7420681.s1	Nearly RB 0	3.2 CD 0	million CD B-noun.quantity	people NNS B-noun.person	in IN 0	this DT 0	country NN B-noun.group	receive VB B-verb.cognition	aminoglycoside IN 0	antibiotics NNS B-noun.person	annually RB B-adv.all	. . 0	. . 0
a11135224.s8	According VBG 0	to TO 0	intention NN B-noun.act	- : 0	to TO 0	- : 0	treat NN B-noun.plant	, , 0	the DT 0	overall JJ B-adj.all	response NN B-noun.communication	rate NN B-noun.time	was VBD B-verb.stative	71.4 CD 0	% NN 0	( ( 0	95 CD 0	% NN 0	CI NNP 0	, , 0	53 CD 0	. . 0	. . 0
a20477932.s5	Memory NN B-noun.person	retrieval NN B-noun.person	of IN 0	experiences NNS B-noun.person	acquired VBN B-verb.possession	prior RB 0	to TO 0	cocaine VB B-verb.social	administration NN B-noun.person	was VBD 0	impaired VBN B-verb.change	and CC 0	negatively RB B-adv.all	correlated VBN B-verb.stative	with IN 0	NFkappaB JJ B-adj.all	activity NN B-noun.process	in IN 0	the DT 0	frontal JJ B-adj.all	cortex NN B-noun.group	. . 0	. . 0
a1592014.s4	Two CD 0	separate JJ B-adj.all	equimolar JJ B-adj.all	doses NNS B-noun.phenomenon	( ( 0	0.2 CD 0	and CC 0	0.4 CD 0	mumol NN B-noun.quantity	) ) 0	of IN 0	either DT 0	cocaine NN B-noun.location	or CC 0	BE NNP 0	were VBD 0	injected VBN B-verb.change	ventricularly RB B-adv.all	in IN 0	unanesthetized JJ B-adj.all	juvenile NN B-noun.location	rats NNS B-noun.person	. . 0	. . 0
a11263551.s2	Treatment NN B-noun.person	strategies NNS I-noun.person	depend VBP B-verb.cognition	on IN 0	the DT 0	correct JJ B-adj.all	diagnosis NN B-noun.cognition	of IN 0	the DT 0	pain NN B-noun.cognition	. . 0	. . 0
a9495837.s13	Affinity NN B-noun.phenomenon	profiles NNS I-noun.phenomenon	of IN 0	( ( 0	+ PRP$ 0	/-)-PG-9 NNP B-noun.person	for IN 0	muscarinic JJ B-adj.all	receptor NN B-noun.person	subtypes NNS B-noun.person	, , 0	determined VBN B-verb.communication	by IN 0	functional JJ B-adj.all	studies NNS B-noun.group	( ( 0	rabbit NN B-noun.person	vas VBD B-verb.stative	deferens NNS B-noun.person	for IN 0	M1 NN 0	, , 0	guinea NN B-noun.person	pig NN B-noun.person	atrium NN B-noun.person	for IN 0	M2 NN 0	, , 0	guinea NN B-noun.person	pig NN B-noun.person	ileum NN B-noun.person	for IN 0	M3 : 0	and CC 0	immature JJ B-adj.all	guinea NN B-noun.person	pig NN B-noun.person	uterus NN B-noun.person	for IN 0	putative JJ B-adj.all	M4 NN 0	) ) 0	, , 0	have VBP 0	shown VBN B-verb.perception	an DT 0	M4/M1 JJ B-adj.all	selectivity NN B-noun.substance	ratio NN B-noun.relation	of IN 0	10.2 CD 0	that WDT 0	might MD 0	be VB B-verb.stative	responsible JJ B-adj.all	for IN 0	the DT 0	antinociception NN B-noun.attribute	and CC 0	the DT 0	anti NNS B-noun.person	- : 0	amnesic JJ B-adj.all	effect NN B-noun.phenomenon	induced VBN B-verb.creation	by IN 0	( ( 0	+ FW 0	/-)-PG-9 FW 0	through IN 0	an DT 0	increase NN B-noun.communication	in_acetylcholine CD 0	extracellular JJ B-adj.all	levels NNS B-noun.state	. . 0	. . 0
a12063090.s8	P<0.05 LS 0	) ) 0	, , 0	suggesting VBG B-verb.communication	the DT 0	partial JJ B-adj.all	involvement NN B-noun.act	of IN 0	the DT 0	opioidergic JJ B-adj.all	system NN B-noun.cognition	in IN 0	the DT 0	synergism NN B-noun.artifact	observed VBN B-verb.perception	. . 0	. . 0
a19269743.s9	Pain NNP B-noun.person	recall NN B-noun.act	after IN 0	one CD B-adj.all	week NN B-noun.time	was VBD 0	similarly RB B-adv.all	precise VB B-verb.creation	( ( 0	magnitude NN B-noun.person	, , 0	p<0.01 NNP B-noun.person	, , 0	duration NN 0	, , 0	p<0.05 NNP B-noun.location	) ) 0	. . 0	. . 0
a3827439.s0	Recurrent NNP B-noun.person	reversible JJ I-noun.person	acute_renal_failure NN I-noun.person	from IN 0	amphotericin NN B-noun.person	. . 0	. . 0
a11745184.s18	CONCLUSIONS NNS B-noun.artifact	, , 0	The DT 0	combination NN B-noun.event	of IN 0	cisplatin NN B-noun.food	and CC 0	amifostine NN B-noun.person	in IN 0	this DT 0	study NN B-noun.communication	resulted VBD B-verb.communication	in IN 0	an DT 0	overall JJ B-adj.all	response NN B-noun.communication	rate NN B-noun.time	of IN 0	16 CD B-adj.all	% NN 0	. . 0	. . 0
a18631865.s1	Massive JJ B-adj.all	urinary JJ B-adj.all	protein NN B-noun.person	excretion NN B-noun.act	has VBZ 0	been VBN 0	observed VBN B-verb.perception	after IN 0	conversion NN B-noun.person	from IN 0	calcineurin NN B-noun.communication	inhibitors NNS B-noun.attribute	to TO 0	mammalian JJ B-adj.all	target NN B-noun.location	of IN 0	rapamycin NN B-noun.substance	( ( 0	mToR NN 0	) ) 0	inhibitors NNS B-noun.person	, , 0	especially RB B-adv.all	sirolimus NN 0	, , 0	in IN 0	renal JJ B-adj.all	transplant NN B-noun.person	recipients NNS B-noun.person	with IN 0	chronic_allograft_nephropathy NNP B-noun.group	. . 0	. . 0
a9284778.s0	Epidemic NNP B-noun.person	of IN 0	liver_disease NN 0	caused VBN B-verb.communication	by IN 0	hydrochlorofluorocarbons NNS B-noun.person	used VBN B-verb.consumption	as IN 0	ozone NN 0	- : 0	sparing NN B-verb.communication	substitutes NNS B-noun.person	of IN 0	chlorofluorocarbons NNS B-noun.artifact	. . 0	. . 0
a3564823.s3	Since IN 0	the DT 0	cranial JJ B-adj.all	condition NN B-noun.act	precluded VBN B-verb.stative	use NN 0	of IN 0	more RBR B-adv.all	usual JJ B-adj.all	methods NNS B-noun.attribute	, , 0	lidocaine NN B-noun.person	was VBD 0	given VBN B-verb.possession	intra NN B-noun.person	- : 0	arterially RB B-adv.all	, , 0	with IN 0	careful JJ B-adj.all	cardiovascular JJ 0	monitoring NN B-verb.perception	, , 0	to TO 0	counteract VB B-verb.contact	the DT 0	vasospasm NN B-noun.artifact	. . 0	. . 0
a7988234.s3	A DT 0	history NN B-noun.cognition	of IN 0	angioedema NN 0	secondary JJ 0	to TO 0	lisinopril VB B-verb.social	therapy NN B-noun.act	was VBD 0	elicited VBN B-verb.emotion	. . 0	. . 0
a8590259.s8	While IN 0	the DT 0	elevations NNS B-noun.artifact	of IN 0	the DT 0	upper JJ B-adj.all	lid NN B-noun.body	margin NN I-noun.body	in IN 0	most JJS 0	subjects NNS B-noun.person	were VBD B-verb.stative	not RB B-adv.all	more JJR B-noun.quantity	than IN 0	2 CD B-adj.all	mm NN B-noun.quantity	and CC 0	did VBD 0	not RB B-adv.all	cause VB B-verb.creation	noticeable JJ B-adj.all	change NN B-noun.act	in IN 0	appearance NN B-noun.act	, , 0	one CD 0	subject NN B-noun.artifact	suffered VBN B-verb.change	from IN 0	mechanical JJ B-adj.all	entropion NN I-noun.phenomenon	and CC 0	marked VBD B-verb.communication	corneal_abrasion JJ B-noun.communication	3 CD B-adj.all	hours NNS B-noun.artifact	after IN 0	instillation NN B-noun.time	of IN 0	the DT 0	medication NN B-noun.artifact	. . 0	. . 0
a19657887.s1	Hydrogen_cyanamide NN 0	is VBZ B-verb.stative	a DT 0	plant NN B-noun.plant	growth NN 0	regulator NN 0	used VBN B-verb.consumption	in IN 0	agriculture NN B-noun.act	to TO 0	induce VB B-verb.cognition	bud CC 0	break NN B-noun.person	in IN 0	fruit NN 0	trees NNS B-noun.plant	. . 0	. . 0
a18821488.s2	Although IN 0	MHb NNP B-noun.person	formers NNS I-noun.person	are VBP 0	generally RB B-adv.all	applied VBN B-verb.stative	as IN 0	treatments NNS B-noun.person	for IN 0	CN NNP 0	poisoning NN B-verb.communication	, , 0	it PRP 0	has VBZ 0	been VBN 0	proposed VBN B-verb.cognition	that IN 0	a DT 0	stable JJ B-adj.all	, , 0	long RB 0	- : 0	acting VBG B-verb.stative	MHb NNP 0	former NN 0	could MD 0	serve VB B-verb.social	as IN 0	a DT 0	CN NNP 0	pretreatment NN B-noun.artifact	. . 0	. . 0
a150790.s2	The DT 0	administration NN B-noun.time	of IN 0	pharmacologic JJ B-adj.pert	doses NNS B-noun.event	of IN 0	pyridoxine_hydrochloride NN B-noun.other	led VBD B-verb.motion	to TO 0	a DT 0	disappearance NN B-noun.act	of IN 0	symptoms NNS B-noun.body	. . 0	. . 0
a7628595.s8	Vitamin_B12 NN B-noun.artifact	and CC 0	folinic_acid JJ B-noun.body	supplementation NN I-noun.body	of IN 0	ZDV NNP 0	therapy NN 0	does VBZ 0	not RB B-adv.all	seem VB B-verb.perception	useful JJ B-adj.all	in IN 0	preventing VBG B-verb.communication	or CC 0	reducing VBG B-verb.change	ZDV NNP B-noun.group	- : 0	induced VBN B-verb.creation	myelotoxicity NN B-noun.attribute	in IN 0	the DT 0	overall JJ B-adj.all	treated JJ B-adj.all	population NN B-noun.person	, , 0	although IN 0	a DT 0	beneficial JJ B-adj.all	effect NN B-noun.cognition	in IN 0	certain JJ B-adj.all	subgroups NNS B-noun.group	of IN 0	patients NNS B-noun.person	can MD 0	not RB B-adv.all	be VB 0	excluded VBN B-verb.social	. . 0	. . 0
a17612891.s10	There EX 0	are VBP 0	also RB B-adj.all	implications NNS B-noun.state	for IN 0	recommendations NNS B-noun.act	and CC 0	regulations NNS B-noun.act	regarding VBG B-verb.stative	the DT 0	use NN 0	of IN 0	clozapine NN B-noun.phenomenon	. . 0	. . 0
a15737522.s5	Of IN 0	those DT 0	, , 0	13 CD 0	( ( 0	26 CD B-adj.all	% NN 0	) ) 0	developed VBD B-verb.creation	biliary JJ B-adj.all	pathology NN B-noun.person	. . 0	. . 0
a16867021.s19	Climbing VBG B-verb.motion	behavior NN B-noun.attribute	induced VBD B-verb.creation	by_apomorphine CD 0	was VBD 0	reduced VBN B-verb.change	in IN 0	animals NNS B-noun.person	treated VBD B-verb.communication	with_THP NN B-noun.person	. . 0	. . 0
a18791946.s5	Despite IN 0	pharmacological JJ B-adj.all	and CC 0	supportive JJ B-noun.person	interventions NNS I-noun.person	, , 0	laboratory NN B-noun.person	parameters NNS B-noun.person	worsened VBD B-verb.social	and CC 0	the DT 0	patient NN B-noun.person	died VBD B-verb.change	17 CD B-adj.all	hours NNS B-noun.artifact	after IN 0	admission NN B-noun.time	. . 0	. . 0
a18560792.s8	RESULTS NNS B-noun.artifact	, , 0	Compared VBN B-verb.cognition	to TO 0	controls NNS B-noun.artifact	, , 0	aortic_regurgitation NN 0	( ( 0	OR CC 0	, , 0	3.1 CD 0	, , 0	95 CD 0	% NN 0	IC NNP 0	, , 0	1.1 CD 0	- : 0	8.8 CD 0	) ) 0	and CC 0	mitral_regurgitation NN B-noun.act	( ( 0	OR CC 0	, , 0	10.7 CD 0	, , 0	95 CD 0	% NN 0	IC NNP 0	, , 0	2.1 CD 0	- : 0	53 LS 0	) ) 0	were VBD B-verb.stative	more RBR B-adv.all	frequent JJ B-adj.all	in IN 0	PD NNP 0	patients NNS B-noun.person	( ( 0	tricuspid JJ 0	, , 0	NS NNP 0	) ) 0	. . 0	. . 0
a9390208.s5	Most JJS 0	of IN 0	these DT 0	patients NNS B-noun.person	had VBD 0	more RBR B-noun.quantity	than IN 0	two CD 0	metastatic JJ B-adj.all	sites NNS B-noun.location	, , 0	with IN 0	lung NN B-noun.person	metastasis NN I-noun.person	predominant NN B-noun.person	. . 0	. . 0
a4027862.s3	Therapeutic JJ B-adj.pert	ranges NNS B-noun.state	for IN 0	antidepressants NNS B-noun.event	that WDT 0	have VBP 0	been VBN 0	derived VBN B-verb.cognition	from IN 0	general JJ B-adj.all	adult NN B-noun.act	population NN I-noun.act	studies NNS B-noun.group	may MD 0	not RB 0	be VB B-verb.stative	appropriate JJ B-adj.all	for IN 0	the DT 0	elderly JJ B-adj.all	. . 0	. . 0
a9727773.s3	Thirty SYM 0	- : 0	five CD B-adj.all	patients NNS B-noun.person	with IN 0	primary_pulmonary_hypertension NN B-noun.attribute	and CC 0	85 CD 0	matched VBN B-verb.possession	controls NNS B-noun.artifact	were VBD 0	recruited VBN B-verb.communication	over IN 0	32 CD 0	months NNS B-noun.person	( ( 0	1992 CD 0	- : 0	1994 CD 0	) ) 0	in IN 0	Belgium NNP B-noun.location	. . 0	. . 0
a8387218.s5	Of IN 0	those DT 0	positive JJ B-adj.all	for IN 0	p24 CD 0	antigen NN 0	at IN 0	the DT 0	commencement NN B-noun.person	of IN 0	the DT 0	study NN B-noun.communication	67 CD B-adj.all	% NN 0	showed VBD B-verb.communication	a DT 0	positive JJ B-adj.all	response NN B-noun.communication	, , 0	and CC 0	this DT 0	was VBD B-verb.stative	most RBS B-adv.all	likely JJ B-adj.all	in IN 0	those DT 0	with IN 0	CD4 : 0	+ PRP$ 0	lymphocyte NN B-noun.artifact	subset NN B-noun.artifact	counts NNS B-noun.artifact	above IN 0	100 CD 0	mm3 CD 0	. . 0	. . 0
a6534871.s3	The DT 0	occurrence NN B-noun.state	of IN 0	infarcts NNS B-noun.phenomenon	were VBD 0	confirmed VBN B-verb.change	by IN 0	histological JJ B-adj.pert	methods NNS B-noun.attribute	. . 0	. . 0
a9660111.s5	In IN 0	the DT 0	acute JJ B-adj.all	experiment NN B-noun.group	TRI NNP B-noun.group	( ( 0	given VBN B-verb.possession	i.p NNP 0	. . 0	) ) 0	. . 0
a3564823.s4	The DT 0	treatment NN B-noun.plant	was VBD 0	rapidly RB B-adv.all	successful JJ B-adj.all	. . 0	. . 0
a15130900.s0	Urinary_bladder_cancer NN B-noun.state	in IN 0	Wegener's_granulomatosis NN 0	, , 0	risks NNS B-noun.body	and CC 0	relation NN B-noun.act	to TO 0	cyclophosphamide VB B-verb.social	. . 0	. . 0
a2578334.s2	The DT 0	initiated JJ B-adj.all	hepatocytes NNS B-noun.person	in IN 0	the DT 0	liver NN B-noun.food	were VBD 0	assayed VBN B-verb.communication	as IN 0	the DT 0	gamma NN B-noun.act	- : 0	glutamyltransferase NN B-noun.person	( ( 0	gamma NN B-noun.act	- : 0	GT NN 0	) ) 0	positive JJ B-adj.all	foci NN B-noun.person	formed VBN B-verb.social	following VBG B-verb.stative	a DT 0	2-week JJ B-adj.all	selection NN B-noun.person	regimen NNS B-noun.person	consisting VBG B-verb.communication	of IN 0	dietary JJ B-adj.all	0.02 CD 0	% NN 0	2-acetylaminofluorene JJ B-adj.all	coupled VBN I-adj.all	with IN 0	a DT 0	necrogenic JJ B-adj.all	dose NN B-noun.event	of IN 0	CCl4 NNP B-noun.person	. . 0	. . 0
a11875660.s1	Anencephaly RB 0	has VBZ 0	been VBN 0	suggested VBN B-verb.communication	to TO 0	develop VB B-verb.communication	from IN 0	exencephaly RB B-adv.all	, , 0	however RB 0	, , 0	there EX 0	is VBZ B-verb.stative	little JJ 0	direct JJ 0	experimental JJ B-adj.all	evidence NN B-noun.attribute	to TO 0	support VB B-verb.contact	this DT 0	, , 0	and CC 0	the DT 0	mechanism NN B-noun.attribute	of IN 0	transformation NN B-noun.act	remains VBZ B-verb.change	unclear JJ B-adj.all	. . 0	. . 0
a137340.s10	And CC 0	the DT 0	results NNS B-noun.communication	are VBP B-verb.stative	consistent JJ B-adj.all	with IN 0	the DT 0	hypothesis NN B-noun.communication	that WDT 0	morphine VBP B-verb.stative	acts NNS B-noun.act	by IN 0	retarding VBG B-verb.motion	the DT 0	release NN B-noun.state	of IN 0	acetylcholine NN B-noun.person	at IN 0	some DT 0	central JJ B-adj.pert	cholinergic JJ B-adj.pert	synapses NNS B-noun.body	. . 0	. . 0
a16867021.s22	Such JJ B-adj.all	effects NNS B-noun.phenomenon	of_THP WDT 0	were VBD 0	reversed VBN B-verb.change	by_RAMH JJ 0	indicating VBG B-verb.communication	the DT 0	involvement NN B-noun.person	of_histamine CD I-noun.person	H(3)-receptors NNS I-noun.person	. . 0	. . 0
a12921865.s7	Allopregnanolone NNP B-noun.person	and CC 0	pregnanolone NN B-noun.person	, , 0	but CC 0	not RB B-adj.all	ganaxolone NN B-noun.person	, , 0	also RB B-adv.all	reduced VBD B-verb.change	cumulative JJ B-adj.all	lethality NN B-noun.communication	associated VBN B-verb.cognition	with IN 0	kindling NN B-noun.act	. . 0	. . 0
a3107448.s5	Both DT 0	patients NNS B-noun.person	recovered VBD B-verb.communication	quickly RB B-adv.all	after IN 0	stopping VBG B-verb.motion	glyburide NN 0	therapy NN 0	and CC 0	have VBP 0	remained VBN B-verb.stative	well RB 0	for IN 0	a DT 0	follow NN B-noun.person	- : 0	up IN 0	period NN B-noun.time	of IN 0	1 CD B-adj.all	year NN B-noun.time	. . 0	. . 0
a19473225.s6	Also RB B-adv.all	the DT 0	frequency NN B-noun.person	of IN 0	abnormal JJ B-adj.all	electro NN B-noun.person	- : 0	diagnostic JJ B-adj.all	findings NNS B-noun.act	showed VBD B-verb.communication	similarity NN B-noun.attribute	between IN 0	the DT 0	two CD 0	groups NNS B-noun.group	( ( 0	G NNP 0	, , 0	7/23 CD 0	= SYM 0	30.4 CD 0	% NN 0	, , 0	P NNP 0	, , 0	6/20 CD 0	= SYM 0	30 CD B-adj.all	% NN 0	) ) 0	. . 0	. . 0
a2578334.s6	The DT 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	hypomethylation NN 0	of IN 0	DNA NNP 0	per FW 0	se FW 0	may MD 0	not RB 0	be VB B-verb.stative	sufficient JJ B-adj.all	for IN 0	initiation NN B-noun.act	. . 0	. . 0
a10406016.s8	They PRP 0	showed VBD B-verb.communication	significantly RB B-adv.all	more RBR B-adv.all	rapid JJ B-adj.all	improvement NN B-noun.state	of IN 0	motor NN 0	function NN B-noun.act	in IN 0	the DT 0	first JJ B-adj.all	week NN B-noun.event	following VBG 0	hemorrhage NN B-noun.attribute	and CC 0	better JJR B-adj.all	memory NN B-noun.person	retention NN B-noun.person	in IN 0	the DT 0	passive JJ B-adj.all	avoidance NN B-noun.act	test NN 0	. . 0	. . 0
a17244258.s8	In IN 0	inflamed JJ B-adj.all	preparations NNS B-noun.person	, , 0	the DT 0	muscarinic JJ B-adj.all	receptor NN B-noun.cognition	antagonism NN B-noun.attribute	on IN 0	the DT 0	phasic JJ B-adj.all	component NN B-noun.relation	of IN 0	the DT 0	electrical JJ B-adj.all	field NN B-noun.cognition	stimulation NN I-noun.cognition	- : 0	evoked JJ B-adj.all	contraction NN B-noun.person	was VBD 0	decreased VBN B-verb.change	and CC 0	the DT 0	pirenzepine NN B-noun.location	and CC 0	4-DAMP JJ 0	antagonism NN B-noun.attribute	on IN 0	the DT 0	tonic JJ B-adj.all	component NN B-noun.artifact	was VBD B-verb.stative	much RB 0	less RBR 0	efficient JJ B-adj.all	than IN 0	in IN 0	controls NNS B-noun.artifact	. . 0	. . 0
a3985451.s0	Warfarin SYM 0	- : 0	induced VBN B-verb.creation	iliopsoas JJ B-adj.all	hemorrhage NN B-noun.person	with IN 0	subsequent JJ B-noun.person	femoral_nerve_palsy NNP I-noun.person	. . 0	. . 0
a3615541.s4	In IN 0	the DT 0	present JJ B-adj.all	experiment NN B-noun.communication	calcitonin NN B-noun.communication	decreased VBD B-verb.communication	locomotor NN B-noun.person	activity NN B-noun.process	when WRB 0	locally RB B-adv.all	injected VBN B-verb.change	into IN 0	the DT 0	same JJ B-adj.all	sites NNS B-noun.location	where WRB 0	it PRP 0	decreases VBZ B-verb.cognition	food NN B-noun.cognition	intake NN I-noun.cognition	. . 0	. . 0
a11807648.s11	In IN 0	contrast NN 0	, , 0	FS NNP 0	containing VBG B-verb.communication	aprotinin NN B-noun.person	did VBD 0	not RB B-adv.all	evoke VB B-verb.change	any DT 0	paroxysmal JJ B-adj.all	activity NN B-noun.process	. . 0	. . 0
a9284778.s4	All DT 0	nine CD 0	exposed VBN B-verb.communication	workers NNS B-noun.person	were VBD 0	affected VBN B-verb.change	to TO 0	various JJ B-adj.all	degrees NNS B-noun.communication	. . 0	. . 0
a8558192.s0	Phase NNP 0	II NNP 0	trial NN 0	of IN 0	vinorelbine NN B-noun.person	in IN 0	metastatic JJ B-adj.all	squamous_cell_esophageal_carcinoma NNP B-noun.group	. . 0	European NNP B-noun.location	Organization NNP I-noun.location	for IN 0	Research NNP B-noun.person	and CC 0	Treatment NNP B-noun.other	of IN I-noun.other	Cancer NNP I-noun.other	Gastrointestinal NNP I-noun.other	Treat NNP I-noun.other	Cancer NNP I-noun.other	Cooperative NNP I-noun.other	Group NNP I-noun.other	. . 0	. . 0
a14659530.s9	Basal NNP B-noun.person	CGRP NNP I-noun.person	concentration NN B-noun.event	was VBD B-verb.stative	significantly RB B-adv.all	higher JJR B-adj.all	and CC 0	platelet VB B-verb.creation	5-HT JJ B-adj.all	content NN B-noun.person	tended VBD B-verb.social	to TO 0	be VB B-verb.stative	lower JJR B-adj.all	in IN 0	subjects NNS B-noun.person	who WP 0	experienced VBD B-verb.perception	a DT 0	migraine NN B-noun.artifact	attack NN B-noun.artifact	. . 0	. . 0
a11263551.s7	The DT 0	reduction NN B-noun.act	of IN 0	cyclosporine- CD 0	or CC 0	tacrolimus NN B-noun.substance	trough NN B-noun.state	levels NNS B-noun.attribute	and CC 0	the DT 0	administration NN B-noun.time	of IN 0	calcium NN 0	channel NN 0	blockers NNS B-noun.person	led VBD B-verb.motion	to TO 0	relief NN B-noun.act	of IN 0	pain NN B-noun.cognition	. . 0	. . 0
a17147461.s1	Sirolimus NNP B-noun.person	is VBZ B-verb.stative	a DT 0	novel JJ B-adj.all	immunosuppressant NN B-noun.feeling	with IN 0	potent JJ B-adj.all	antiproliferative JJ B-adj.all	actions NNS B-noun.process	through IN 0	its PRP$ 0	ability NN B-noun.motive	to TO 0	inhibit VB B-verb.change	the DT 0	raptor NN B-noun.person	- : 0	containing VBG B-verb.stative	mammalian JJ B-adj.all	target NN B-noun.location	of IN 0	rapamycin NN B-noun.phenomenon	protein NN B-noun.substance	kinase NN B-noun.state	. . 0	. . 0
a2522601.s2	This DT 0	is VBZ B-verb.stative	the DT 0	first JJ B-adj.all	report NN B-noun.communication	of IN 0	such PDT 0	an DT 0	unusual JJ B-adj.all	reaction NN B-noun.process	to TO 0	carbamazepine VB B-verb.social	. . 0	. . 0
a17241784.s0	Progressive JJ B-adj.all	myopathy NN B-noun.person	with IN 0	up SYM 0	- : 0	regulation NN B-noun.act	of IN 0	MHC NNP B-noun.group	- : 0	I PRP 0	associated VBN B-verb.cognition	with IN 0	statin NN B-adj.all	therapy NN B-noun.act	. . 0	. . 0
a8682684.s6	The DT 0	hypotensive JJ B-adj.all	episodes NNS B-noun.person	were VBD B-verb.stative	severe JJ B-adj.all	enough NN B-noun.person	to TO 0	require VB B-verb.communication	vasopressor JJ B-adj.all	administration NN B-noun.person	. . 0	. . 0
a21029050.s2	The DT 0	duration NN 0	of IN 0	action NN B-noun.process	may MD 0	be VB 0	prolonged VBN B-verb.creation	in IN 0	patients NNS B-noun.person	with IN 0	genetic JJ B-adj.all	variants NNS B-noun.cognition	of IN 0	the DT 0	butyrylcholinesterase NN 0	enzyme NN 0	( ( 0	BChE NN 0	) ) 0	, , 0	the DT 0	most RBS 0	common JJ 0	being VBG B-verb.stative	the DT 0	K- : 0	and CC 0	the DT 0	A SYM 0	- : 0	variants NNS B-noun.person	. . 0	. . 0
a16938416.s8	No DT 0	association NN B-noun.person	was VBD 0	found VBN B-verb.communication	for IN 0	hormone NN 0	use VB B-verb.consumption	less JJR B-noun.quantity	than IN 0	1 CD B-adj.all	year NN B-noun.time	. . 0	. . 0
a1919871.s3	There EX 0	was VBD B-verb.stative	no DT 0	evidence NN B-noun.attribute	of IN 0	repair NN B-noun.person	to TO 0	the DT 0	damaged VBN B-verb.change	medullary JJ B-adj.all	interstitial JJ B-adj.all	matrix NN B-noun.person	, , 0	or CC 0	proliferation NN B-noun.act	of IN 0	remaining VBG B-verb.change	undamaged JJ B-adj.all	type NN B-noun.cognition	1 CD B-adj.all	medullary JJ B-adj.all	interstitial JJ B-noun.body	cells NNS I-noun.body	after IN 0	the DT 0	recovery NN B-noun.process	period NN B-noun.time	following VBG B-verb.stative	analgesic JJ B-adj.all	treatment NN B-noun.plant	. . 0	. . 0
a8955532.s1	Cellular JJ B-adj.all	mechanisms NNS B-noun.shape	which WDT 0	account VBP 0	for IN 0	disruption NN B-noun.act	the DT 0	blood NN B-noun.act	- : 0	brain NN B-noun.food	barrier NN B-noun.artifact	during IN 0	acute JJ B-adj.all	hypertension NN 0	are VBP 0	not RB B-adv.all	clear JJ B-adj.all	. . 0	. . 0
a10526274.s6	Treatment NN B-noun.person	was VBD 0	comprised VBN B-verb.communication	of IN 0	VNB NNP B-noun.group	, , 0	25 CD 0	mg PRP 0	/ : 0	m(2 LS 0	) ) 0	, , 0	plus CC 0	GEM NNP 0	, , 0	1000 CD 0	mg NN B-noun.quantity	/ : 0	m(2 LS 0	) ) 0	, , 0	both DT 0	on IN 0	Days NNS B-noun.time	1 CD 0	, , 0	8 CD B-adj.all	, , 0	and CC 0	15 CD 0	every DT 0	28 CD B-adj.all	days NNS B-noun.person	. . 0	. . 0
a16574712.s5	The DT 0	latter JJ B-adj.all	two CD 0	deficits NNS B-noun.person	remained VBD B-verb.stative	significant JJ B-adj.all	after IN 0	controlling VBG B-verb.social	for IN 0	other JJ 0	drug NN 0	use NN 0	. . 0	. . 0
a19269743.s11	These DT 0	results NNS B-noun.communication	indicate VBP B-verb.communication	a DT 0	reliable JJ B-adj.all	memory NN B-noun.person	for IN 0	magnitude NN B-noun.person	and CC 0	duration NN B-noun.act	of IN 0	experimentally RB B-adv.all	induced VBN B-verb.creation	pain NN B-noun.cognition	. . 0	. . 0
a2578334.s0	5-azacytidine JJ B-adj.all	potentiates NNS B-noun.event	initiation_induced_by_carcinogens NNS 0	in IN 0	rat NN 0	liver NN 0	. . 0	. . 0
a10526274.s5	All DT 0	patients NNS B-noun.person	were VBD B-verb.stative	evaluable JJ B-adj.all	for IN 0	response NN B-noun.communication	and CC 0	toxicity NN B-noun.attribute	. . 0	. . 0
a9931093.s4	In IN 0	addition NN 0	, , 0	the DT 0	effect NN B-noun.cognition	of IN 0	the DT 0	specific JJ B-adj.all	endothelin NN B-noun.person	type NN B-noun.person	A DT 0	receptor NN B-noun.person	antagonist JJ B-adj.pert	FR_139317 NN B-noun.person	on IN B-adv.all	FK_506-induced JJ B-adj.all	hypertension NN B-noun.person	in IN 0	rats NNS B-noun.animal	was VBD 0	studied VBN B-verb.cognition	. . 0	. . 0
a12584269.s6	In IN 0	the DT 0	' '' 0	conscious JJ B-adj.all	catheterized VBN B-verb.stative	rat NN 0	' '' 0	model NN B-noun.person	, , 0	the DT 0	glomerular JJ B-adj.all	filtration NN B-noun.process	rate NN B-noun.time	( ( 0	GFR NNP 0	) ) 0	was VBD 0	measured VBN B-verb.cognition	as IN 0	the DT 0	clearance NN B-noun.group	of IN I-noun.group	Cr(EDTA NNP I-noun.group	) ) 0	. . 0	. . 0
a2425813.s1	Liver_enlargement NN B-noun.artifact	and CC 0	muscle_wastage NN B-noun.body	occurred VBD B-verb.stative	in IN 0	Wistar NNP B-noun.other	rats NNS B-noun.artifact	following VBG B-verb.stative	the DT 0	subcutaneous JJ B-adj.all	administration NN B-noun.time	of IN 0	prednisolone NN B-noun.person	. . 0	. . 0
a20080419.s1	In IN 0	this DT 0	study NN B-noun.artifact	, , 0	we PRP 0	investigated VBD B-verb.communication	the DT 0	therapeutic JJ B-adj.pert	potential NN B-noun.state	of IN 0	bone NN 0	marrow NN 0	mononuclear NN B-noun.body	cells NNS B-noun.body	( ( 0	BMCs NNS B-noun.person	) ) 0	in IN 0	a DT 0	model NN B-noun.person	of IN 0	epilepsy NN B-noun.communication	induced VBN B-verb.creation	by IN 0	pilocarpine NN B-noun.person	in IN 0	rats NNS B-noun.animal	. . 0	. . 0
a19759529.s5	This DT 0	study NN B-noun.communication	aimed VBN B-verb.communication	at IN 0	investigating VBG B-verb.stative	the DT 0	potential JJ B-adj.all	antipsychotic JJ B-adj.pert	- : 0	like IN 0	properties NNS B-noun.attribute	of IN 0	SSR103800 NN 0	, , 0	with IN 0	a DT 0	particular JJ B-adj.all	focus NN B-noun.person	on IN 0	models NNS B-noun.artifact	of IN 0	hyperactivity NN B-noun.attribute	, , 0	involving VBG B-verb.stative	either DT 0	drug NN B-noun.artifact	challenge NN 0	( ( 0	ie UH 0	, , 0	amphetamine JJ B-adj.all	and CC 0	MK-801 NNP B-noun.other	) ) 0	or CC 0	transgenic JJ B-adj.all	mice NNS B-noun.animal	( ( 0	ie UH 0	, , 0	NMDA NNP B-noun.group	Nr1(neo-/- NNP I-noun.group	) ) 0	and CC 0	DAT(-/- NNP B-noun.location	) ) 0	) ) 0	. . 0	. . 0
a14659530.s1	The DT 0	aim NN 0	of IN 0	the DT 0	present JJ B-adj.all	study NN B-noun.artifact	was VBD 0	to TO 0	investigate VB B-verb.communication	changes NNS B-noun.phenomenon	in IN 0	the DT 0	plasma NN B-noun.plant	calcitonin_gene SYM 0	- : 0	related_peptide JJ B-noun.other	( ( 0	CGRP NNP 0	) ) 0	concentration NN B-noun.quantity	and CC 0	platelet NN 0	serotonin NN 0	( ( 0	5-hydroxytriptamine JJ 0	, , 0	5-HT NNP B-noun.location	) ) 0	content NN B-noun.quantity	during IN 0	the DT 0	immediate JJ B-adj.all	headache NN B-noun.state	and CC 0	the DT 0	delayed VBN B-verb.change	genuine JJ B-adj.all	migraine NN B-noun.artifact	attack NN B-noun.artifact	provoked VBN B-verb.communication	by IN 0	nitroglycerin NN B-noun.person	. . 0	. . 0
a2802551.s5	Concentrations NNS B-noun.person	of IN 0	amphotericin NN 0	B NNP 0	in IN 0	plasma NN B-noun.substance	were VBD B-verb.stative	not RB B-adv.all	significantly RB B-adv.all	different JJ B-adv.all	among IN 0	the DT 0	three CD 0	groups NNS 0	at IN 0	any DT 0	time NN B-noun.possession	during IN 0	the DT 0	study NN B-noun.artifact	. . 0	. . 0
a6747681.s10	A DT 0	delayed JJ B-adj.all	complication NN B-noun.person	in IN 0	nine CD B-adj.all	patients NNS B-noun.person	has VBZ 0	been VBN B-verb.stative	unilateral JJ B-adj.all	loss_of_vision NN B-noun.event	secondary JJ B-adj.all	to TO 0	a DT 0	retinal_vasculitis NN B-noun.location	. . 0	. . 0
a7504976.s6	One CD 0	of IN 0	the DT 0	latter JJ B-adj.all	two CD 0	patients NNS B-noun.person	further RB B-adv.all	experienced VBD B-verb.communication	a DT 0	cytolytic JJ B-adj.all	hepatitis NN B-noun.state	which WDT 0	appeared VBD B-verb.change	after IN 0	Benzylthiouracil NNP B-noun.person	( ( 0	Basd__ne NN B-noun.event	) ) 0	had VBD 0	replaced VBN B-verb.possession	carbimazole NN I-verb.possession	. . 0	. . 0
a14659530.s5	In IN 0	those DT 0	subjects NNS B-noun.person	who WP 0	had VBD B-verb.social	no DT 0	migraine NN 0	attack NN B-noun.substance	( ( 0	11 CD 0	subjects NNS B-noun.artifact	) ) 0	a DT 0	similar JJ B-adj.all	time NN B-noun.person	schedule NN B-noun.person	was VBD 0	used VBN B-verb.consumption	. . 0	. . 0
a1378968.s4	When WRB 0	comparing VBG B-verb.cognition	all DT 0	lithium NN B-noun.substance	treated VBN B-verb.change	versus NN 0	non RB 0	- : 0	lithium NN B-noun.person	- : 0	treated VBN B-verb.communication	groups NNS B-noun.group	, , 0	lithium NN B-noun.person	caused VBD B-verb.communication	a DT 0	reduction NN B-noun.act	in IN 0	glomerular JJ B-adj.all	filtration NN B-noun.process	rate NN B-noun.time	( ( 0	GFR NNP 0	) ) 0	without IN 0	significant JJ B-adj.all	changes NNS B-noun.relation	in IN 0	effective JJ B-adj.all	renal JJ B-adj.all	plasma NN B-noun.attribute	flow NN B-noun.process	( ( 0	as IN 0	determined VBN B-verb.communication	by IN 0	a DT 0	marker NN B-noun.person	secreted VBN B-verb.possession	into IN 0	the DT 0	proximal JJ B-adj.all	tubules NNS B-noun.artifact	) ) 0	or CC 0	lithium JJ B-adj.all	clearance NN B-noun.attribute	. . 0	. . 0
a12589964.s22	CONCLUSIONS NNS B-noun.artifact	, , 0	Among IN 0	markers NNS 0	of IN 0	ischemic_injury NN B-noun.other	after IN 0	DOX NNP B-noun.group	in IN 0	rats NNS B-noun.animal	, , 0	cTnT NNP B-noun.person	showed VBD B-verb.communication	the DT 0	greatest JJS B-adj.all	ability NN B-noun.person	to TO 0	detect VB B-verb.cognition	myocardial_damage NN 0	assessed VBN B-verb.communication	by IN 0	echocardiographic JJ B-adj.pert	detection NN B-noun.act	and CC 0	histological JJ B-noun.body	changes NNS I-noun.body	. . 0	. . 0
a16740173.s22	The DT 0	analysed JJ 0	carbachol NN 0	concentration NN 0	exceeded VBD B-verb.stative	the DT 0	supposed VBN B-adj.all	serum NN B-noun.body	level NN B-noun.state	resulting VBG B-verb.stative	from IN 0	a DT 0	therapeutic JJ B-adj.all	dose NN B-noun.act	by IN 0	a DT 0	factor NN B-noun.person	of IN 0	130 CD 0	to TO 0	260 CD 0	. . 0	. . 0
a2559236.s1	The DT 0	effect NN B-noun.cognition	of IN 0	the DT 0	converting VBG B-verb.possession	enzyme JJ B-adj.all	inhibitor NN B-noun.person	( ( 0	CEI NNP 0	) ) 0	enalapril NN B-noun.phenomenon	was VBD 0	assessed VBN B-verb.cognition	in IN 0	Munich NNP B-noun.person	- : 0	Wistar NN B-noun.person	rats NNS B-noun.person	with IN 0	established JJ B-adj.all	adriamycin NN B-noun.person	nephrosis NN B-noun.person	. . 0	. . 0
a7977601.s7	There EX 0	were VBD B-verb.stative	13 CD B-adj.all	cases NNS B-noun.quantity	of IN 0	adverse JJ B-adj.all	reactions NNS B-noun.cognition	( ( 0	0.34 CD 0	% NN 0	) ) 0	, , 0	ten CD 0	of IN 0	which WDT 0	were VBD B-verb.stative	mild JJ B-adj.all	reactions NNS B-noun.act	such JJ 0	as IN 0	nausea NN B-noun.group	, , 0	exanthema NN B-noun.person	, , 0	urtication NN B-noun.act	, , 0	itchiness NN 0	, , 0	and CC 0	urgency NN B-noun.person	to TO 0	defecate VB B-verb.communication	, , 0	and CC 0	did VBD 0	not RB B-adv.all	require VB B-verb.consumption	treatment NN I-verb.consumption	. . 0	. . 0
a8739323.s8	Histologic JJ B-adj.pert	changes NNS B-noun.phenomenon	were VBD 0	found VBN B-verb.possession	in IN 0	rat NN 0	kidneys NNS B-noun.person	after IN 0	administration NN B-noun.time	of IN 0	MTX NNP B-noun.group	, , 0	CY NNP 0	and CC 0	NG NNP 0	, , 0	while IN 0	no DT 0	such JJ B-adj.all	change NN B-noun.possession	was VBD 0	observed VBN B-verb.perception	after IN 0	5-FU NN B-noun.person	and CC 0	joint JJ B-adj.all	administration NN B-noun.time	of IN 0	MTX NNP B-noun.group	+ POS 0	5-FU NN B-noun.artifact	+ '' 0	CY NNP 0	compared VBN B-verb.cognition	to TO 0	controls NNS B-noun.cognition	. . 0	. . 0
a9855119.s0	Clinical JJ B-noun.person	and CC 0	histopathologic JJ B-adj.pert	examination NN B-noun.act	of IN 0	renal JJ B-adj.all	allografts NNS B-noun.person	treated VBN B-verb.social	with IN 0	tacrolimus NN B-noun.person	( ( 0	FK506 NNP 0	) ) 0	for IN 0	at IN 0	least JJS 0	one CD 0	year NN B-noun.time	. . 0	. . 0
a14765563.s1	Although IN 0	the DT 0	United NNP B-noun.other	States NNPS I-noun.other	Food NNP I-noun.other	and CC 0	Drug NNP B-noun.group	Administration NNP I-noun.group	banned VBD B-verb.social	its PRP$ 0	use NN B-noun.attribute	for IN 0	nocturnal_leg_cramps RB 0	due JJ 0	to TO 0	lack NN B-noun.person	of IN 0	safety NN B-noun.person	and CC 0	efficacy NN B-noun.person	, , 0	quinine NN B-noun.location	is VBZ B-verb.stative	widely RB B-adv.all	available JJ B-adj.all	in IN 0	beverages NNS 0	including VBG B-verb.stative	tonic JJ B-adj.all	water NN B-noun.object	and CC 0	bitter JJ B-adj.all	lemon NN B-noun.person	. . 0	. . 0
a19729346.s5	For IN 0	almost RB B-verb.possession	all DT 0	cognitive JJ B-adj.all	measures NNS B-noun.food	, , 0	there EX 0	were VBD B-verb.stative	no DT 0	medication NN B-noun.act	by IN 0	age NN B-noun.person	- : 0	interaction NN B-noun.possession	effects NNS B-noun.phenomenon	, , 0	which WDT 0	indicates VBZ B-verb.communication	that IN 0	the DT 0	2 CD B-adj.all	age NN B-noun.person	groups NNS B-noun.group	exhibited VBD B-verb.stative	similar JJ B-adj.all	responses NNS B-noun.act	to TO 0	the DT 0	medication NN B-noun.artifact	challenge NN B-noun.artifact	. . 0	. . 0
a7988234.s4	Current JJ B-noun.person	medications NNS I-noun.person	did VBD 0	not RB B-adv.all	include VB B-verb.change	angiotensin NN B-noun.group	- : 0	converting VBG B-verb.communication	enzyme JJ B-adj.all	inhibitors NNS B-noun.person	or CC 0	beta JJ B-noun.body	- : 0	blockers NNS B-noun.person	. . 0	. . 0
a19308880.s2	Some DT 0	case NN B-noun.state	reports NNS B-noun.communication	are VBP 0	published VBN B-verb.creation	in IN 0	the DT 0	literature NN B-noun.act	but CC 0	no DT 0	systematic JJ B-adj.all	study NN B-noun.artifact	from IN 0	a DT 0	sample NN B-noun.cognition	of IN 0	patients NNS B-noun.person	has VBZ 0	been VBN 0	published VBN B-verb.creation	. . 0	. . 0
a3970039.s7	Cyclophosphamide NNP B-noun.person	therapy NN I-noun.person	increases VBZ B-verb.stative	the DT 0	risk NN 0	of IN 0	carcinoma_of_the_bladder NN B-noun.group	. . 0	. . 0
a150790.s8	The DT 0	patient NN B-noun.person	has VBZ 0	been VBN 0	followed VBN B-verb.social	for IN 0	six CD 0	years NNS B-noun.act	and CC 0	has VBZ 0	required VBN B-verb.stative	pharmacologic JJ B-adj.all	doses NNS B-noun.event	of IN 0	pyridoxine NN 0	to TO 0	control VB B-verb.social	her PRP$ 0	behavior NN B-noun.attribute	. . 0	. . 0
a19473225.s1	Toxic NNP B-noun.person	peripheral_neuropathy NNP I-noun.person	is VBZ B-verb.stative	still RB B-adv.all	a DT 0	significant JJ B-adj.all	limiting VBG B-verb.social	factor NN B-noun.person	for IN 0	chemotherapy NN B-noun.act	with IN 0	paclitaxel NN B-noun.artifact	( ( 0	PAC NNP 0	) ) 0	, , 0	although IN 0	glutamate NN B-noun.person	and CC 0	its PRP$ 0	closely RB B-adj.all	related VBN I-adj.all	amino_acid JJ B-adj.all	glutamine NN B-noun.person	were VBD 0	claimed VBN B-verb.communication	to TO 0	ameliorate VB B-verb.communication	PAC NNP B-noun.person	neurotoxicity NN I-noun.person	. . 0	. . 0
a3437726.s10	Three CD 0	months NNS 0	later RB B-adv.all	the DT 0	patient NN B-noun.person	was VBD 0	exposed VBN B-verb.perception	to TO 0	a DT 0	single JJ B-adj.all	dose NN B-noun.event	of IN 0	metoprolol NN B-noun.food	, , 0	diltiazem NN B-noun.person	, , 0	propafenone NN B-noun.person	( ( 0	since IN 0	he PRP 0	had VBD 0	received VBN B-verb.possession	this DT 0	drug NN B-noun.group	in IN 0	the DT 0	past NN B-noun.location	) ) 0	, , 0	and CC 0	sparteine NN B-noun.person	( ( 0	as IN 0	a DT 0	probe NN B-noun.person	for IN 0	the DT 0	debrisoquine NN B-noun.communication	/ : 0	sparteine JJ B-adj.all	type NN B-noun.person	polymorphism NN B-noun.cognition	of IN 0	oxidative JJ B-adj.all	drug NN B-noun.group	metabolism NN B-noun.attribute	) ) 0	. . 0	. . 0
a19037603.s5	Lamivudine NN 0	therapy NN 0	was VBD 0	started VBN B-verb.creation	3 CD B-adj.all	- : 0	7 CD B-adj.all	days NNS B-noun.act	prior RB 0	to TO 0	immunosuppressive JJ B-adj.all	therapy NN B-noun.person	in IN 0	all DT 0	patients NNS B-noun.person	. . 0	. . 0
a20588063.s6	RESULTS NNS B-noun.artifact	, , 0	By IN 0	day NN 0	2 CD 0	, , 0	some DT 0	patchy JJ B-adj.all	foot NN B-noun.act	process NN I-noun.act	effacement NN B-noun.cognition	, , 0	but CC 0	no DT 0	proteinuria NN B-noun.person	, , 0	appeared VBD B-verb.change	. . 0	. . 0
a2484011.s4	Amantadine JJ B-adj.all	treatment NN B-noun.communication	produced VBD B-verb.creation	a DT 0	biphasic JJ B-adj.all	effect NN B-noun.cognition	on IN 0	mouse NN 0	motility NN 0	. . 0	. . 0
a7802851.s10	CONCLUSIONS NNS B-noun.artifact	, , 0	Alprazolam NNP B-noun.person	caused VBD B-verb.creation	side NN B-noun.artifact	- : 0	effects NNS B-noun.phenomenon	and CC 0	adverse JJ B-adj.all	effects NNS B-noun.phenomenon	during IN 0	treatment NN B-noun.plant	but CC 0	many JJ 0	patients NNS B-noun.person	were VBD 0	willing JJ 0	to TO 0	accept VB B-verb.communication	these DT 0	. . 0	. . 0
a15325671.s1	INTRODUCTION NN 0	, , 0	Cyclophosphamide NNP B-noun.person	is VBZ B-verb.stative	an DT 0	alkylating VBG B-verb.communication	agent NN B-noun.person	given VBN B-verb.possession	frequently RB B-adv.all	as IN 0	a DT 0	component NN B-noun.person	of IN 0	many JJ 0	conditioning NN B-noun.person	regimens VBZ B-verb.communication	. . 0	. . 0
a18726058.s5	Topical JJ B-adj.all	papaverine NN B-noun.person	was VBD 0	used VBN B-verb.consumption	as IN 0	a DT 0	direct JJ 0	therapeutic JJ 0	action NN 0	to TO 0	manage VB B-verb.social	vasospasm NN B-noun.attribute	in IN 0	a DT 0	total NN B-noun.state	of IN 0	11 CD B-adj.all	patients NNS B-noun.person	. . 0	. . 0
a10457883.s1	A DT 0	case NN B-noun.state	of IN 0	recurarization NN B-noun.act	in IN 0	the DT 0	recovery NN B-noun.artifact	room NN I-noun.artifact	is VBZ 0	reported VBN B-verb.communication	. . 0	. . 0
a9522143.s1	The DT 0	cause NN B-noun.act	of IN 0	hearing_loss NN B-noun.location	after IN 0	spinal JJ B-adj.all	anaesthesia NN B-noun.object	is VBZ B-verb.stative	unknown JJ B-adj.all	. . 0	. . 0
a16005948.s5	GNC92H2 NN B-noun.person	was VBD 0	delivered VBN B-verb.possession	30 CD 0	min NN 0	before RB 0	, , 0	concomitantly RB B-adv.all	or CC 0	3 CD B-adj.all	min NN B-noun.communication	after IN 0	cocaine NN B-noun.relation	treatment NN I-noun.relation	. . 0	. . 0
a9698967.s5	Both DT 0	the DT 0	temporal JJ B-adj.all	relationship NN B-noun.state	of IN 0	events NNS B-noun.plant	and CC 0	the DT 0	response NN B-noun.communication	to TO 0	treatment NN B-noun.act	suggest VBP B-verb.communication	that IN 0	a DT 0	rapid JJ B-adj.all	systemic JJ B-adj.all	absorption NN B-noun.event	of IN 0	mepivacaine NN B-noun.person	with IN 0	adrenaline JJ B-adj.all	and/or NN B-noun.artifact	interaction NN B-noun.act	of IN 0	these DT 0	drugs NNS B-noun.artifact	with IN 0	the DT 0	patient NN B-noun.person	's POS 0	cardiovascular JJ B-adj.all	medications NNS B-noun.artifact	were VBD B-verb.stative	responsible JJ B-adj.all	for IN 0	the DT 0	perioperative JJ B-adj.all	complications NNS B-noun.person	. . 0	. . 0
a11007689.s7	However RB 0	, , 0	literature NN B-noun.communication	regarding VBG B-verb.stative	the DT 0	incidence NN B-noun.event	of IN 0	the DT 0	recurrence NN B-noun.act	of IN 0	TMA NNP B-noun.group	in IN 0	patients NNS B-noun.person	exposed VBD B-verb.communication	sequentially RB B-adv.all	to TO 0	cyclosporine VB B-verb.social	and CC 0	tacrolimus NN B-noun.person	is VBZ 0	limited VBN B-verb.change	. . 0	. . 0
a3101906.s1	Ketoconazole NNP B-noun.person	was VBD 0	introduced VBN B-verb.contact	in IN 0	the DT 0	United NNP B-noun.group	Kingdom NNP I-noun.group	in IN 0	1981 CD 0	. . 0	. . 0
a2696505.s1	In IN 0	a DT 0	randomized JJ B-adj.all	study NN B-noun.artifact	, , 0	labetalol NN B-noun.act	- : 0	induced VBN B-verb.creation	hypotension NN 0	and CC 0	nitroprusside NN B-noun.person	- : 0	induced VBN B-verb.creation	hypotension NN 0	were VBD 0	compared VBN B-verb.change	in IN 0	20 CD B-adj.all	patients NNS B-noun.person	( ( 0	10 CD B-adj.all	in IN 0	each DT 0	group NN 0	) ) 0	scheduled VBN B-verb.cognition	for IN 0	major JJ B-adj.all	orthopedic JJ B-adj.all	procedures NNS B-noun.person	. . 0	. . 0
a18004067.s4	Possible JJ B-adj.all	risk NN B-noun.plant	factors NNS B-noun.person	for IN 0	the DT 0	development NN B-noun.process	of IN 0	hepatotoxicity NN B-noun.state	in IN 0	patients NNS B-noun.person	treated VBD B-verb.social	with IN 0	therapeutic JJ B-adj.all	doses NNS B-noun.event	of IN 0	paracetamol NN B-noun.act	are VBP 0	discussed VBN B-verb.communication	. . 0	. . 0
a11672959.s2	Cervical JJ B-adj.all	and CC 0	inguinal JJ B-adj.all	lymph NN B-noun.person	node NN I-noun.person	biopsies NNS B-noun.person	showed VBD B-verb.communication	the DT 0	features NNS B-noun.cognition	of IN 0	severe JJ 0	necrotising VBG B-verb.consumption	lymphadenitis NN I-verb.consumption	, , 0	associated VBN B-verb.cognition	with IN 0	erythrophagocytosis NN B-noun.food	and CC 0	prominent JJ B-adj.all	eosinophilic JJ B-adj.all	infiltrates NNS B-noun.cognition	, , 0	without IN 0	viral JJ B-adj.all	inclusion NN B-noun.possession	bodies NNS B-noun.object	, , 0	suggestive NN 0	of IN 0	an DT 0	adverse_drug_reaction NN B-noun.act	. . 0	. . 0
a9522143.s5	Patients NNS B-noun.person	given VBN B-verb.possession	prilocaine NN B-noun.person	were VBD B-verb.stative	more RBR B-adv.all	likely JJ B-adj.all	to TO 0	develop VB B-verb.communication	hearing_loss NNP B-noun.person	( ( 0	10 CD 0	out IN 0	of IN 0	22 CD 0	) ) 0	than IN 0	those DT 0	given VBN B-verb.possession	bupivacaine NN B-noun.substance	( ( 0	4 CD 0	out IN 0	of IN 0	22 CD 0	) ) 0	( ( 0	P NNP 0	< $ 0	0.05 CD 0	) ) 0	. . 0	. . 0
a14596845.s6	Nine CD 0	days NNS 0	later RB 0	locomotor NN 0	activity NN B-noun.person	was VBD 0	measured VBN B-verb.cognition	in IN 0	response NN B-noun.communication	to TO 0	a DT 0	single JJ B-adj.all	low JJ B-adj.all	dose NN B-noun.quantity	of IN 0	amphetamine NN B-noun.person	( ( 0	0.5 CD 0	mg PRP B-noun.quantity	/ : 0	kg LS 0	) ) 0	. . 0	. . 0
a1720453.s0	Long RB 0	- DT 0	term NN B-noun.time	follow VB B-verb.stative	- : 0	up IN 0	of IN 0	ifosfamide JJ B-adj.all	renal_toxicity NN B-noun.state	in IN 0	children NNS B-noun.person	treated VBN B-verb.social	for IN 0	malignant_mesenchymal_tumors NNS B-noun.person	, , 0	an DT 0	International NNP B-noun.other	Society NNP I-noun.other	of IN I-noun.other	Pediatric NNP I-noun.other	Oncology NNP I-noun.other	report NN B-noun.communication	. . 0	. . 0
a8092427.s16	Diagnosis NN B-noun.person	of IN 0	these DT 0	patients NNS B-noun.person	can MD 0	be VB 0	achieved VBN B-verb.social	only RB B-adv.all	if IN 0	specific JJ B-adj.all	AX NNP B-noun.group	- : 0	related JJ B-adj.all	reagents NNS B-noun.person	are VBP 0	employed VBN B-verb.consumption	. . 0	. . 0
a8558192.s12	At IN 0	least JJS 0	one CD 0	episode NN B-noun.communication	of IN 0	grade NN B-noun.communication	3 CD 0	or CC 0	4 CD B-adj.all	granulocytopenia NN B-noun.quantity	was VBD 0	seen VBN B-verb.perception	in IN 0	59 CD 0	% NN 0	of IN 0	patients NNS B-noun.person	. . 0	. . 0
a18809400.s8	These DT 0	findings NNS B-noun.act	suggest VBP B-verb.communication	that IN 0	alpha LS 0	- : 0	lipoic_acid NN B-noun.group	might MD 0	reduce VB B-verb.change	the DT 0	risk NN 0	of IN 0	developing VBG B-verb.communication	peripheral_nerve_toxicity NN B-noun.person	in IN 0	patients NNS B-noun.person	undergoing VBG B-verb.communication	chemotherapy NN B-noun.communication	and CC 0	encourage VB B-verb.social	further RBR B-adv.all	confirmatory JJ B-adj.all	clinical JJ B-adj.all	trials NNS B-noun.communication	. . 0	. . 0
a17020434.s8	Preliminary JJ B-adj.all	studies NNS B-noun.act	suggest VBP B-verb.communication	that IN 0	statins NNS B-noun.person	could MD 0	interfere VB B-verb.contact	with IN 0	the DT 0	risk NN 0	of IN 0	recurrence NN B-noun.act	after IN 0	electrical JJ B-adj.all	cardioversion NN B-noun.act	. . 0	. . 0
a424937.s1	Twelve CD 0	patients NNS B-noun.person	with IN 0	liver_disease NN 0	related VBN B-verb.communication	to TO 0	methyldopa NN B-noun.person	were VBD 0	seen VBN B-verb.perception	between IN 0	1967 CD 0	and CC 0	1977 CD 0	. . 0	. . 0
a10706004.s10	The DT 0	_ ( 0	K(Na NNP 0	) ) 0	value NN B-noun.possession	for IN 0	Na+ NNP B-noun.person	returned VBD B-verb.communication	to TO 0	control VB B-verb.possession	value NN B-noun.possession	. . 0	. . 0
a1749407.s2	In IN 0	individuals NNS 0	with IN 0	preexisting VBG B-verb.stative	, , 0	high JJ B-noun.group	- : 0	grade NN B-noun.attribute	coronary JJ B-adj.all	arterial JJ B-adj.all	narrowing NN B-noun.act	, , 0	acute_myocardial_infarction NN B-noun.act	may MD 0	result VB B-verb.stative	from IN 0	an DT 0	increase NN B-noun.act	in IN 0	myocardial JJ B-adj.all	oxygen NN 0	demand NN B-noun.communication	associated VBN B-verb.cognition	with IN 0	cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	increase NN B-noun.process	in IN 0	rate NN B-noun.time	- : 0	pressure NN B-noun.act	product NN I-noun.act	. . 0	. . 0
a8437969.s3	The DT 0	arrhythmias NNS B-noun.body	were VBD B-verb.stative	temporally RB B-adv.all	related VBN B-verb.cognition	to TO 0	cimetidine VB B-verb.change	administration NN B-noun.time	, , 0	disappeared VBD B-verb.emotion	after IN 0	dechallenge NN B-noun.time	, , 0	and CC 0	did VBD 0	not RB B-adv.all	recur VB B-verb.perception	during IN 0	ranitidine JJ B-adj.all	treatment NN B-noun.plant	. . 0	. . 0
a10737864.s5	Age SYM 0	- : 0	related VBN B-verb.cognition	changes NNS B-noun.phenomenon	in IN 0	ultrasound JJ B-adj.all	production NN B-noun.artifact	corresponded VBD B-verb.stative	with IN 0	changes NNS B-noun.food	in IN 0	cardiovascular JJ B-adj.all	variables NNS B-noun.artifact	, , 0	including VBG B-verb.change	baseline JJ B-adj.all	cardiac JJ B-adj.all	rate NN B-noun.time	and CC 0	clonidine NN B-noun.person	- : 0	induced VBN B-verb.creation	bradycardia NNS B-noun.person	. . 0	. . 0
a16904497.s0	Cauda_equina_syndrome VBN B-verb.contact	after IN 0	epidural JJ B-adj.all	steroid JJ B-adj.all	injection NN B-noun.event	, , 0	a DT 0	case NN B-noun.state	report NN B-noun.communication	. . 0	. . 0
a1749407.s0	Cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	myocardial_infarction NN B-noun.artifact	, , 0	clinical JJ B-adj.all	observations NNS B-noun.motive	and CC 0	pathogenetic JJ B-adj.all	considerations NNS B-noun.communication	. . 0	. . 0
a2265898.s0	Serial JJ B-adj.all	epilepsy NN B-noun.person	caused VBN B-verb.communication	by IN 0	levodopa NN B-noun.communication	/ : 0	carbidopa NN B-noun.person	administration NN B-noun.person	in IN 0	two CD 0	patients NNS B-noun.person	on IN 0	hemodialysis NN B-noun.location	. . 0	. . 0
a2355241.s2	The DT 0	leading VBG B-adj.all	causes NNS B-noun.event	of IN 0	death NN B-noun.state	were VBD B-verb.stative	pneumonia NN B-noun.person	and CC 0	bronchitis NN 0	( ( 0	44.1 CD 0	% NN 0	) ) 0	, , 0	malignant JJ B-adj.all	neoplasms NNS B-noun.cognition	( ( 0	11.6 CD 0	% NN 0	) ) 0	, , 0	heart_diseases NNS B-noun.location	( ( 0	4.1 CD 0	% NN 0	) ) 0	, , 0	cerebral_infarction NN 0	( ( 0	3.7 CD 0	% NN 0	) ) 0	and CC 0	septicaemia NN B-noun.body	( ( 0	3.3 CD 0	% NN 0	) ) 0	. . 0	. . 0
a2924746.s4	In IN 0	the DT 0	course NN B-noun.location	of IN 0	developing VBG B-verb.cognition	this DT 0	model NN B-noun.person	, , 0	a DT 0	common JJ B-noun.person	vehicle NN B-noun.communication	, , 0	propylene_glycol NN B-noun.person	, , 0	by IN 0	itself PRP 0	in IN 0	high JJ B-adj.all	doses NNS B-noun.artifact	, , 0	was VBD 0	found VBN B-verb.cognition	to TO 0	exhibit VB B-verb.body	protective JJ B-adj.all	properties NNS B-noun.attribute	against IN 0	induced VBN B-verb.creation	seizures NNS B-noun.artifact	and CC 0	inhibited VBD B-verb.change	weight_gain NNP I-verb.change	. . 0	. . 0
a10706004.s12	After IN 0	recovery NN B-noun.process	of IN 0	blood NN B-noun.phenomenon	pressure NN I-noun.phenomenon	to TO 0	control VB B-verb.social	values NNS B-noun.attribute	, , 0	the DT 0	extrusion NN B-noun.act	of IN 0	Na+ CD 0	from IN 0	cardiac JJ B-adj.all	cells NNS B-noun.body	was VBD 0	normalized VBN B-verb.communication	, , 0	as IN 0	revealed VBN B-verb.perception	by IN 0	restoration NN B-noun.act	of IN 0	the DT 0	( ( 0	Na,,K)-ATPase JJ 0	activity NN B-noun.state	. . 0	. . 0
a2224762.s6	Granulocyte NNP B-noun.person	nadir NN B-noun.person	was VBD B-verb.stative	on IN 0	day NN 0	14 CD 0	( ( 0	range NN B-noun.person	, , 0	4 CD B-adj.all	- : 0	22 LS 0	) ) 0	. . 0	. . 0
a15649445.s4	every DT 0	other JJ 0	day NN 0	for IN 0	3 CD B-adj.all	days NNS B-noun.person	caused VBD B-verb.communication	a DT 0	significant JJ B-adj.all	increase NN B-noun.event	in IN 0	vacuous JJ B-adj.all	chewing NN B-noun.communication	, , 0	tongue NN B-noun.person	protrusion NN B-noun.person	and CC 0	duration NN B-noun.act	of IN 0	facial JJ B-adj.all	twitching NN B-noun.act	, , 0	compared VBN B-verb.cognition	to TO 0	the DT 0	control NN B-noun.act	. . 0	. . 0
a6203452.s0	Thrombotic_microangiopathy JJ 0	and CC 0	renal_failure NN B-noun.act	associated VBN B-verb.cognition	with IN 0	antineoplastic JJ B-adj.all	chemotherapy NN B-noun.body	. . 0	. . 0
a8558192.s15	CONCLUSION NN B-noun.group	, , 0	These DT 0	data NNS B-noun.cognition	indicate VBP B-verb.communication	that IN 0	VNB NNP 0	is VBZ B-verb.stative	an DT 0	active JJ B-adj.all	agent NN B-noun.person	in IN 0	metastatic JJ B-adj.all	esophageal_squamous_cell_carcinoma NNP B-noun.other	. . 0	. . 0
a15275829.s3	A DT 0	gene NN B-noun.state	cluster NN I-noun.state	comprises VBZ B-verb.change	the DT 0	alpha3 NN B-noun.other	, , 0	alpha5 NNP B-noun.person	and CC 0	beta4 JJ 0	subunits NNS B-noun.person	, , 0	which WDT 0	coassemble JJ B-adj.all	to TO 0	form VB B-verb.stative	functional JJ B-adj.all	receptors NNS B-noun.person	. . 0	. . 0
a17439425.s4	We PRP 0	studied VBD B-verb.cognition	the DT 0	role NN B-noun.attribute	of IN 0	xanthine JJ B-adj.all	oxidase NN B-noun.process	( ( 0	XO NNP 0	) ) 0	, , 0	which WDT 0	is VBZ 0	implicated VBN B-verb.change	in IN 0	the DT 0	production NN B-noun.artifact	of IN 0	reactive JJ B-adj.all	oxygen NN B-noun.body	species NNS I-noun.body	, , 0	in IN 0	dexamethasone NN 0	- : 0	induced VBN B-verb.creation	hypertension NN 0	( ( 0	dex NN B-noun.person	- : 0	HT NN 0	) ) 0	. . 0	. . 0
a12653683.s10	Conversely RB B-adv.all	, , 0	down RB 0	- : 0	regulation NN B-noun.act	of IN 0	alphaENaC NNP B-noun.other	, , 0	betaENaC JJ 0	and CC 0	gammaENaC NNP B-noun.location	mRNA NNP I-noun.location	expression NN B-noun.communication	on IN 0	day NN 0	3 CD 0	occurred VBD B-verb.stative	in IN 0	the DT 0	presence NN B-noun.person	of IN 0	high JJ B-adj.all	aldosterone NN B-noun.artifact	concentrations NNS B-noun.artifact	, , 0	and CC 0	was VBD 0	followed VBN B-verb.stative	by IN 0	a DT 0	return NN B-noun.event	of IN 0	sodium NN 0	excretion NN 0	to TO 0	control VB B-verb.social	values NNS B-noun.attribute	. . 0	. . 0
a11147747.s1	Many JJ 0	new JJ B-adj.all	serotonergic_antidepressants NNS B-noun.group	have VBP 0	been VBN 0	introduced VBN B-verb.contact	over IN 0	the DT 0	past JJ B-adj.all	decade NN B-noun.attribute	. . 0	. . 0
a15233872.s6	The DT 0	results NNS B-noun.communication	show VBP B-verb.communication	that DT 0	pretreatment NN B-noun.person	with IN 0	TCR NNP B-noun.group	may MD 0	be VB B-verb.stative	useful JJ B-adj.all	in IN 0	preventing VBG B-verb.creation	the DT 0	damage NN 0	induced VBN B-verb.creation	by IN 0	isoproterenol NN B-noun.person	in IN 0	rat JJ B-adj.all	heart NN B-noun.body	. . 0	. . 0
a8643971.s15	Two CD 0	pathologic JJ B-adj.all	complete JJ B-adj.all	responses NNS B-noun.person	were VBD 0	observed VBN B-verb.perception	in IN 0	patients NNS B-noun.person	who WP 0	had VBD 0	achieved VBN B-verb.social	clinical JJ B-adj.all	complete JJ B-adj.all	responses NNS B-noun.communication	. . 0	. . 0
a16428221.s5	We PRP 0	conclude VBP B-verb.cognition	that DT 0	methylphenidate NN B-noun.person	mediated VBD B-verb.change	vasculitis NN B-noun.artifact	should MD 0	be VB 0	considered VBN B-verb.cognition	in IN 0	patients NNS B-noun.person	with IN 0	neurological JJ B-adj.all	symptoms NNS B-noun.body	and CC 0	a DT 0	history NN B-noun.cognition	of IN 0	methylphenidate NN B-noun.person	therapy NN B-noun.person	. . 0	. . 0
a16330293.s16	Fewer JJR B-adj.all	than IN 0	6 CD B-adj.all	% NN 0	of IN 0	patients NNS B-noun.person	in IN 0	either DT 0	group NN B-noun.location	were VBD 0	considered VBN B-verb.cognition	by IN 0	the DT 0	investigator NN B-noun.person	to TO 0	have VB B-verb.social	a DT 0	worsening VBG 0	of IN 0	their PRP$ 0	overall JJ 0	disease NN 0	condition NN 0	during IN 0	the DT 0	study NN B-noun.artifact	. . 0	. . 0
a16740173.s18	Serum NNP B-noun.person	samples NNS B-noun.cognition	from IN 0	the DT 0	first JJ B-adj.all	and CC 0	second JJ B-adj.all	days NNS B-noun.artifact	contained VBD B-verb.stative	3.6 CD 0	and CC 0	1.9 CD 0	mg FW B-noun.quantity	/ FW 0	l FW 0	carbachol NN 0	, , 0	respectively RB B-adv.all	. . 0	. . 0
a10835440.s7	In IN 0	multivariate JJ B-adj.all	analysis NN B-noun.food	, , 0	a DT 0	significant JJ B-adj.all	correlation NN B-noun.cognition	between IN 0	DBP_reduction NN B-noun.act	and CC 0	worsening VBG B-verb.social	of IN 0	the DT 0	neurological JJ B-adj.all	score NN B-noun.group	was VBD 0	found VBN B-verb.communication	for IN 0	the DT 0	high JJ B-noun.group	- : 0	dose NN 0	group NN 0	( ( 0	beta=0.49 RB 0	, , 0	P=0 NNP B-noun.person	. . 0	. . 0
a1378968.s6	Lithium NNP B-noun.person	also RB I-noun.person	caused VBD B-verb.communication	proteinuria NNS B-noun.person	and CC 0	systolic JJ B-adj.all	hypertension NN B-noun.act	in IN 0	absence NN B-noun.act	of IN 0	glomerulosclerosis NN B-noun.food	. . 0	. . 0
a3970039.s1	Immunosuppressive JJ B-adj.all	drugs NNS B-noun.artifact	have VBP 0	been VBN 0	used VBN B-verb.consumption	during IN 0	the DT 0	last JJ B-adj.all	30 CD B-adj.all	years NNS B-noun.time	in IN 0	treatment NN B-noun.communication	of IN 0	patients NNS B-noun.person	with IN 0	severe JJ B-adj.all	rheumatoid_arthritis NN B-noun.state	. . 0	. . 0
a18410508.s2	Cardona NNP 0	et FW 0	al FW 0	. . 0	[ PRP 0	. . 0
a20067456.s7	Men NNS B-noun.person	who WP 0	received VBD B-verb.possession	bupropion NN B-noun.communication	had VBD 0	a DT 0	significant JJ B-adj.all	increase NN B-noun.event	in IN 0	the DT 0	total JJ B-adj.all	IIEF NNP B-noun.group	score NN B-noun.group	( ( 0	54.4 CD 0	% NN 0	vs IN 0	1.2 CD 0	% NN 0	, , 0	P= $ 0	0.003 CD 0	) ) 0	, , 0	and CC 0	in IN 0	the DT 0	five CD 0	different JJ B-adj.all	domains NNS B-noun.person	of IN 0	the DT 0	IIEF NNP B-noun.group	. . 0	. . 0
a8372922.s6	The DT 0	actual JJ B-adj.all	frequencies NNS B-noun.person	deafened VBN B-verb.social	were VBD 0	determined VBN B-verb.communication	by IN 0	the DT 0	loss NN B-noun.process	of IN 0	tone NN B-noun.attribute	- : 0	burst NN B-noun.person	elicited VBD B-verb.emotion	auditory JJ B-adj.all	brainstem NN B-noun.plant	responses NNS B-noun.body	. . 0	. . 0
a15233872.s1	Tincture_of_Crataegus JJ 0	( ( 0	TCR NNP 0	) ) 0	, , 0	an DT 0	alcoholic_extract_of_the_berries_of_hawthorn JJ B-noun.person	( ( I-noun.person	Crataegus_oxycantha NNP I-noun.person	) ) 0	, , 0	is VBZ 0	used VBN B-verb.consumption	in IN 0	herbal JJ 0	and CC 0	homeopathic JJ B-adj.pert	medicine NN B-noun.person	. . 0	. . 0
a11587867.s1	We PRP 0	report VBP B-verb.communication	on IN 0	two CD 0	fatal JJ B-adj.all	cases NNS B-noun.state	of IN 0	accidental JJ B-adj.all	intrathecal JJ B-adj.all	vincristine NN B-noun.process	instillation NN I-noun.process	in IN 0	a DT 0	5-year JJ 0	old JJ B-adj.all	girl NN B-noun.person	with IN 0	recurrent NN B-noun.person	acute_lymphoblastic_leucemia NNP I-noun.person	and CC 0	a DT 0	57-year JJ 0	old JJ B-adj.all	man NN B-noun.person	with IN 0	lymphoblastic_lymphoma NNP B-noun.group	. . 0	. . 0
a12757899.s1	Estrogens NNS B-noun.artifact	protect VBP 0	ovariectomized VBN B-verb.creation	rats NNS B-noun.animal	from IN 0	hippocampal_injury NN B-noun.communication	induced VBN B-verb.creation	by IN 0	kainic_acid JJ B-noun.person	- : 0	induced VBN B-verb.creation	status_epilepticus NNP 0	( ( 0	SE NNP 0	) ) 0	. . 0	. . 0
a8701950.s1	We PRP 0	describe VBP B-verb.stative	3 CD B-adj.all	episodes NNS B-noun.quantity	of IN 0	microangiopathic_hemolytic_anemia NNP B-noun.location	( ( 0	MAHA NNP B-noun.group	) ) 0	in IN 0	2 CD B-adj.all	solid JJ B-adj.all	organ NN B-noun.artifact	recipients NNS B-noun.person	under IN 0	FK506 NNP B-noun.person	( ( 0	tacrolimus NN 0	) ) 0	therapy NN 0	. . 0	. . 0
a16938416.s6	In IN 0	almost RB B-adj.all	half NN B-noun.time	of IN 0	these DT 0	women NNS B-noun.person	severe JJ B-verb.contact	atherosclerosis NN 0	of IN 0	the DT 0	aorta NN B-noun.person	was VBD B-verb.stative	present JJ B-adj.all	( ( 0	n=11 NN 0	) ) 0	, , 0	while IN 0	in IN 0	women NNS B-noun.person	without IN 0	hormone NN 0	use NN 0	severe JJ 0	atherosclerosis NN 0	of IN 0	the DT 0	aorta NN B-noun.person	was VBD B-verb.stative	present JJ B-adj.all	in IN 0	less JJR 0	than IN 0	20 CD B-adj.all	% NN 0	( ( 0	OR CC 0	3.1 CD 0	, , 0	95 CD 0	% NN 0	CI NNP 0	, , 0	1.1 CD 0	- : 0	8.5 CD 0	, , 0	adjusted VBN B-verb.change	for IN 0	age NN B-noun.time	, , 0	years NNS 0	since IN 0	menopause NN B-noun.food	, , 0	smoking NN B-verb.consumption	, , 0	and CC 0	body NN B-noun.object	mass NN I-noun.object	index NN B-noun.act	) ) 0	. . 0	. . 0
a1616457.s2	Rats NNS B-noun.person	were VBD 0	trained VBN B-verb.cognition	to TO 0	approach VB B-verb.social	a DT 0	shelf NN B-noun.artifact	where WRB 0	they PRP 0	received VBD B-verb.possession	food NN B-noun.food	reinforcement NN B-noun.artifact	. . 0	. . 0
a10669626.s8	This DT 0	observation NN B-noun.communication	suggests VBZ B-verb.communication	that IN 0	increased VBN B-verb.change	susceptibility NN 0	to TO 0	Warfarin NNP B-noun.person	- : 0	induced VBN B-verb.creation	artery_calcification NN 0	could MD 0	be VB 0	related VBN B-verb.cognition	to TO 0	higher JJR B-adj.all	serum NN B-noun.body	phosphate NN I-noun.body	levels NNS B-noun.state	. . 0	. . 0
a18417364.s5	NIN NNP B-noun.person	- : 0	induced VBN B-verb.creation	midpontine NN B-noun.body	activation NN B-noun.process	may MD 0	correspond VB B-verb.cognition	to TO 0	activation NN B-noun.act	of IN 0	the DT 0	dorsomedial JJ B-adj.all	pontine NN B-noun.state	nuclei NN I-noun.state	and CC 0	the DT 0	nucleus JJ B-noun.group	reticularis NN 0	tegmenti NN B-noun.artifact	pontis NN I-noun.artifact	, , 0	structures NNS B-noun.person	known VBN B-verb.cognition	to TO 0	participate VB B-verb.social	in IN 0	the DT 0	generation NN B-noun.time	of IN 0	multidirectional JJ B-adj.all	saccades NNS B-noun.act	and CC 0	smooth JJ B-adj.all	pursuit NN B-noun.artifact	eye NN 0	movements NNS B-noun.communication	. . 0	. . 0
a8437969.s2	A DT 0	40-year JJ 0	- : 0	old JJ B-adj.all	man NN B-noun.person	with IN 0	leukemia NN B-noun.person	and CC 0	no DT 0	history NN B-noun.cognition	of IN 0	cardiac_disease NNP B-noun.group	developed VBD B-verb.creation	recurrent NN B-noun.artifact	, , 0	brief JJ B-adj.all	episodes NNS B-noun.communication	of IN 0	apparent JJ B-adj.all	sinus_arrest NN 0	while IN 0	receiving VBG B-verb.communication	continuous JJ B-adj.pert	- : 0	infusion NN B-noun.communication	cimetidine NN B-noun.communication	50 CD B-adj.all	mg RB B-noun.quantity	/ JJ 0	hour NN 0	. . 0	. . 0
a20098969.s10	CLINICAL JJ B-adj.all	SIGNIFICANCE NN B-noun.communication	, , 0	This DT 0	clinical JJ B-adj.all	case NN B-noun.state	showing VBG B-verb.perception	oral JJ B-noun.body	manifestations NNS I-noun.body	of IN 0	meth_mouth NNP B-noun.object	was VBD 0	presented VBN B-verb.communication	to TO 0	help VB B-verb.stative	dental JJ B-adj.all	practitioners NNS B-noun.person	recognize VBP B-verb.perception	and CC 0	manage VB B-verb.social	patients NNS B-noun.person	who WP 0	may MD 0	be VB 0	abusing VBG B-verb.change	methamphetamines NNS B-noun.object	. . 0	. . 0
a15233872.s4	TCR NNP B-noun.group	prevented VBD B-verb.creation	the DT 0	isoproterenol NN B-noun.person	- : 0	induced VBN B-verb.creation	decrease NN B-noun.process	in IN 0	antioxidant JJ B-adj.all	enzymes NNS B-noun.person	in IN 0	the DT 0	heart NN B-noun.body	and CC 0	increased VBD B-verb.change	the DT 0	rate NN B-noun.time	of IN 0	ADP NNP B-noun.group	- : 0	stimulated VBD B-verb.communication	oxygen NN B-noun.person	uptake NN B-noun.act	and CC 0	respiratory JJ B-adj.all	coupling NN B-noun.artifact	ratio NN I-noun.artifact	. . 0	. . 0
a347884.s3	The DT 0	daily JJ B-adj.pert	dose NN B-noun.substance	( ( 0	initial JJ B-adj.all	dose NN B-noun.act	, , 0	1 CD B-adj.all	mg NN B-noun.quantity	, , 0	mean JJ B-adj.all	dose NN 0	at IN 0	the DT 0	end NN B-noun.time	of IN 0	the DT 0	trial NN B-noun.act	, , 0	4.47 CD 0	mg NN B-noun.quantity	) ) 0	was VBD B-verb.stative	always RB B-adv.all	administered VBN B-verb.perception	in IN 0	one CD 0	single JJ B-adj.all	dose NN B-noun.communication	. . 0	. . 0
a18726058.s8	FINDINGS NNS B-noun.act	, , 0	A DT 0	temporal JJ B-adj.all	relationship NN B-noun.state	was VBD 0	found VBN B-verb.possession	between IN 0	topical JJ B-adj.all	papaverine NN B-noun.person	and CC 0	BAEP NNP B-noun.other	changes NNS B-noun.artifact	leading VBG B-verb.stative	to TO 0	complete VB B-verb.communication	waveform NN B-noun.attribute	loss NN B-noun.process	. . 0	. . 0
a17244258.s5	In IN 0	both DT 0	types NNS B-noun.person	, , 0	purinoceptor NN B-noun.person	desensitization NN B-noun.person	with IN 0	alpha NN B-noun.food	, , 0	beta JJ 0	- : 0	methylene_adenosine-5'-triphosphate NN B-noun.attribute	( ( 0	alpha NN B-noun.animal	, , 0	beta JJ 0	- : 0	meATP NN B-noun.attribute	) ) 0	caused VBD B-verb.communication	further JJ B-adj.all	reductions NNS B-noun.person	at IN 0	low JJ B-adj.all	frequencies NNS B-noun.person	( ( 0	< $ 0	10 CD B-adj.all	Hz NNP 0	) ) 0	. . 0	. . 0
a18726058.s16	Recommendations NNS B-noun.person	to TO 0	avoid VB B-verb.social	potential JJ B-adj.all	cranial_nerve_deficits NNS B-noun.location	from IN 0	papaverine NN B-noun.person	are VBP 0	provided VBN B-verb.communication	. . 0	. . 0
a3985451.s1	We PRP 0	present VBP B-verb.communication	the DT 0	case NN B-noun.state	of IN 0	a DT 0	28-year JJ 0	- : 0	old JJ B-adj.all	man NN B-noun.person	on IN 0	chronic JJ B-adj.all	warfarin NN B-noun.act	therapy NN B-noun.person	who WP 0	sustained VBD B-verb.body	a DT 0	minor JJ B-adj.all	muscle_tear NN B-noun.act	and CC 0	developed VBD B-verb.creation	increasing VBG B-verb.change	pain NN B-noun.cognition	and CC 0	a DT 0	flexure NN B-noun.person	contracture NN B-noun.person	of IN 0	the DT 0	right JJ B-adj.all	hip NN 0	. . 0	. . 0
a6203452.s3	Histologic JJ B-adj.pert	examination NN B-noun.act	of IN 0	the DT 0	renal JJ B-adj.all	tissue NN B-noun.person	showed VBD B-verb.communication	evidence NN B-noun.attribute	of IN 0	intravascular_coagulation NN B-noun.act	, , 0	primarily RB B-adv.all	affecting VBG B-verb.change	the DT 0	small JJ B-adj.all	arteries NNS B-noun.group	, , 0	arterioles NNS B-noun.artifact	, , 0	and CC 0	glomeruli NNS B-noun.person	. . 0	. . 0
a18186898.s4	Tacrolimus NN B-noun.person	, , 0	MMF NNP 0	, , 0	and CC 0	steroids NNS B-noun.plant	were VBD 0	given VBN B-verb.possession	as IN 0	immunosuppressant JJ B-adj.all	. . 0	. . 0
a3101906.s5	The DT 0	mean JJ B-adj.all	age NN 0	of IN 0	patients NNS B-noun.person	in IN 0	the DT 0	16 CD B-adj.all	probable JJ B-adj.all	cases NNS B-noun.person	was VBD B-verb.stative	57.9 CD 0	, , 0	with IN 0	hepatotoxicity NN 0	being VBG B-verb.stative	more JJR B-adv.all	common JJ B-noun.person	in IN 0	women NNS B-noun.person	. . 0	. . 0
a424937.s0	Patterns NNS B-noun.person	of IN 0	hepatic_injury NNP 0	induced VBN B-verb.creation	by IN 0	methyldopa NN B-noun.person	. . 0	. . 0
a3076126.s7	Ophthalmological JJ B-adj.all	examinations NNS B-noun.motive	in IN 0	over IN 0	1100 CD 0	patients NNS B-noun.person	treated VBD B-verb.social	with IN 0	one CD 0	or CC 0	the DT 0	other JJ B-adj.all	agent NN B-noun.person	have VBP 0	revealed VBN B-verb.perception	no DT 0	evidence NN B-noun.attribute	of IN 0	significant JJ B-adj.all	short JJ B-adj.all	term NN B-noun.time	( ( 0	up IN 0	to TO 0	2 CD B-adj.all	years NNS B-noun.time	) ) 0	cataractogenic JJ B-adj.pert	potential NN B-noun.state	. . 0	. . 0
a20080983.s7	Compared VBN B-verb.cognition	with IN 0	placebo NN B-noun.substance	, , 0	modafinil NN B-noun.person	decreased VBD B-verb.change	nighttime RB B-adv.all	sleep JJ B-adj.all	latency NN B-noun.person	and CC 0	increased VBD B-verb.change	slow JJ B-adj.all	- : 0	wave VBP B-verb.stative	sleep JJ B-adj.all	time NN B-noun.time	in IN 0	cocaine NN 0	- : 0	dependent JJ B-adj.all	participants NNS B-noun.person	. . 0	. . 0
a17532790.s3	Dis NNP B-noun.person	. . 0	, , 0	. . 0
a10365197.s4	Introduction NN 0	of IN 0	the DT 0	DSM NNP B-noun.group	- : 0	IV NN 0	diagnosis NN 0	of IN 0	CIMD NNP B-noun.group	did VBD 0	not RB B-adv.all	substantially RB B-adv.all	affect VB B-verb.change	rates NNS B-noun.time	of IN 0	the DT 0	other JJ B-adj.all	depressive_disorders NNS B-noun.person	. . 0	. . 0
a6773726.s1	The DT 0	effect NN B-noun.cognition	of IN 0	nitroglycerin NN B-noun.person	on IN 0	heart NN 0	rate NN B-noun.time	and CC 0	systolic JJ B-adj.all	blood NN B-noun.group	pressure NN B-noun.person	was VBD 0	compared VBN B-verb.change	in IN 0	5 CD B-adj.all	normal JJ B-adj.all	subjects NNS B-noun.person	, , 0	12 CD B-adj.all	diabetic JJ B-adj.all	subjects NNS B-noun.person	without IN 0	autonomic_neuropathy JJ B-adj.all	, , 0	and CC 0	5 CD B-adj.all	diabetic JJ B-adj.all	subjects NNS B-noun.person	with IN 0	autonomic_neuropathy JJ 0	. . 0	. . 0
a4812392.s4	Liver NN B-noun.person	biopsies NNS B-noun.group	should MD 0	be VB 0	undertaken VBN B-verb.cognition	at IN 0	regular JJ B-adj.all	intervals NNS B-noun.food	if IN 0	azathioprine JJ B-adj.all	therapy NN B-noun.person	is VBZ 0	continued VBN B-verb.stative	so RB B-adv.all	that IN 0	structural JJ B-adj.all	liver_damage NN B-noun.possession	may MD 0	be VB 0	detected VBN B-verb.perception	at IN 0	an DT 0	early JJ B-adj.all	and CC 0	reversible JJ B-adj.all	stage NN B-noun.artifact	. . 0	. . 0
a17615423.s0	Severe JJ B-adj.all	rhabdomyolysis NN B-noun.state	and CC 0	acute_renal_failure JJ B-adj.all	secondary JJ B-adj.all	to TO 0	concomitant JJ B-adj.all	use NN 0	of IN 0	simvastatin NN B-noun.act	, , 0	amiodarone NN 0	, , 0	and CC 0	atazanavir NN B-noun.person	. . 0	. . 0
a19820426.s0	Twin JJ B-adj.all	preterm JJ B-adj.all	neonates NNS B-noun.artifact	with IN 0	cardiac_toxicity NN B-noun.feeling	related VBN B-verb.communication	to TO 0	lopinavir VB B-verb.change	/ : 0	ritonavir NN B-noun.person	therapy NN 0	. . 0	. . 0
a1749407.s8	The DT 0	finding NN B-noun.act	of IN 0	cocaine NN B-noun.person	- : 0	induced VBN B-verb.creation	vasoconstriction NN B-noun.process	in IN 0	segments NNS B-noun.person	of IN 0	( ( 0	noninnervated JJ 0	) ) 0	human JJ B-adj.all	umbilical JJ B-noun.body	artery NN I-noun.body	suggests VBZ B-verb.communication	that IN 0	the DT 0	presence NN B-noun.person	or CC 0	absence NN B-noun.act	of IN 0	intact JJ B-adj.all	innervation NN B-noun.time	is VBZ B-verb.stative	not RB B-adv.all	sufficient JJ B-adj.all	to TO 0	explain VB B-verb.communication	the DT 0	discrepant JJ B-adj.all	data NNS B-noun.cognition	involving VBG B-verb.stative	the DT 0	possibility NN B-noun.state	of IN 0	alpha NN B-noun.act	- : 0	mediated JJ B-adj.all	effects NNS B-noun.phenomenon	. . 0	. . 0
a10743446.s6	The DT 0	following JJ 0	were VBD 0	measured VBN B-verb.cognition	, , 0	spontaneous JJ B-adj.all	pain NN B-noun.person	, , 0	pain NN B-noun.person	evoked VBN B-verb.emotion	by IN 0	punctate NN B-noun.person	and CC 0	brush JJ B-adj.all	stimuli NNS B-noun.artifact	( ( 0	VAS NNP 0	) ) 0	, , 0	and CC 0	areas NNS B-noun.location	of IN 0	brush NN B-noun.person	- : 0	evoked JJ B-verb.emotion	and CC 0	punctate VB B-verb.social	- : 0	evoked JJ B-adj.all	hyperalgesia NN B-noun.person	. . 0	. . 0
a8919272.s0	Morphological JJ B-adj.all	features NNS B-noun.feeling	of IN 0	encephalopathy JJ B-adj.all	after IN 0	chronic JJ B-adj.pert	administration NN B-noun.time	of IN 0	the DT 0	antiepileptic JJ B-adj.all	drug NN B-noun.group	valproate NN B-noun.attribute	to TO 0	rats NNS B-noun.animal	. . 0	A DT 0	transmission NN B-noun.communication	electron NN B-noun.artifact	microscopic NN I-noun.artifact	study NN B-noun.artifact	of IN 0	capillaries NNS B-noun.food	in IN 0	the DT 0	cerebellar JJ B-adj.all	cortex NN B-noun.artifact	. . 0	. . 0
a809711.s7	Our PRP$ 0	results NNS B-noun.communication	suggest VBP B-verb.communication	that IN 0	addition NN 0	of IN 0	phenylephrine NN 0	to TO 0	nitroglycerin NN B-noun.person	is VBZ B-verb.stative	not RB B-adv.all	beneficial JJ B-adj.all	in IN 0	the DT 0	treatment NN B-noun.communication	of IN 0	patients NNS B-noun.person	with IN 0	acute_myocardial_infarction NN B-noun.act	. . 0	. . 0
a7890216.s7	Of IN 0	the DT 0	12 CD B-adj.all	patients NNS B-noun.person	considered VBN B-verb.cognition	for IN 0	oral JJ B-adj.all	ursodeoxycholic_acid NNP B-noun.other	( ( 0	UDCA NNP B-noun.group	) ) 0	treatment NN B-noun.communication	, , 0	two CD 0	had VBD 0	a DT 0	blocked VBN B-verb.body	cystic JJ B-adj.all	duct NN B-noun.state	and CC 0	were VBD B-verb.stative	not RB B-adv.all	started VBN B-verb.perception	on IN 0	UDCA NNP B-noun.group	while IN 0	one CD 0	was VBD 0	lost VBN B-verb.possession	to TO 0	follow VB B-verb.possession	up RP I-verb.possession	. . 0	. . 0
a9931093.s11	kg-1 JJ 0	. . 0	. . 0
a10091617.s7	A DT 0	lesser JJR B-adj.all	degree NN B-noun.person	of IN 0	orthostatic_hypotension NN B-noun.group	occurred VBD B-verb.cognition	with IN 0	standing NN B-verb.contact	. . 0	. . 0
a9522152.s5	However RB 0	, , 0	we PRP 0	suggest VBP B-verb.communication	that IN 0	a DT 0	low JJ B-adj.all	solution NN B-noun.phenomenon	concentration NN B-noun.event	should MD 0	be VB 0	preferred VBN B-verb.cognition	for IN 0	unilateral JJ B-adj.all	spinal JJ B-adj.all	anaesthesia NN 0	with IN 0	a DT 0	hyperbaric JJ B-adj.all	anaesthetic JJ B-adj.all	solution NN B-noun.cognition	( ( 0	if IN 0	pencil NN B-noun.person	- : 0	point NN B-adj.all	needle NN B-noun.state	and CC 0	slow JJ B-adj.all	injection NN B-noun.event	rate NN B-noun.time	are VBP 0	employed VBN B-verb.consumption	) ) 0	, , 0	in IN 0	order NN 0	to TO 0	minimize VB B-verb.change	the DT 0	risk NN 0	of IN 0	a DT 0	localized VBN B-verb.stative	high JJ B-adj.all	peak JJ B-adj.all	anaesthetic JJ B-adj.all	concentration NN B-noun.event	, , 0	which WDT 0	might MD 0	lead VB B-verb.cognition	to TO 0	a DT 0	transient JJ B-adj.all	neurological_deficit NN B-noun.act	. . 0	. . 0
a20619828.s8	This DT 0	novel JJ B-adj.all	model NN B-noun.act	of IN 0	OCD NNP B-noun.group	demonstrates VBZ B-verb.cognition	that IN 0	drug NN 0	exposure NN 0	during IN 0	a DT 0	sensitive JJ B-adj.all	period NN B-noun.person	can MD 0	program VB B-verb.social	disease NN B-noun.act	- : 0	like IN 0	systems NNS B-noun.body	permanently RB B-adv.all	, , 0	which WDT 0	could MD 0	have VB B-verb.perception	implications NNS B-noun.act	for IN 0	current JJ B-adj.all	and CC 0	future JJ B-adj.all	therapeutic JJ B-adj.pert	strategies NNS B-noun.attribute	for IN 0	this DT 0	and CC 0	other JJ B-adj.all	psychiatric_disorders NNS B-noun.person	. . 0	. . 0
a16330293.s4	METHODS NNS B-noun.attribute	, , 0	This DT 0	was VBD B-verb.stative	a DT 0	multicenter NN B-noun.person	, , 0	randomized VBD B-verb.cognition	, , 0	open JJ B-noun.person	- : 0	label NN B-noun.substance	study NN B-noun.artifact	in IN 0	adult NN B-noun.act	smokers NNS I-noun.act	with IN 0	heart_disease NN B-noun.state	, , 0	hypertension NN 0	not RB 0	controlled VBN B-verb.social	by IN 0	medication NN B-noun.person	, , 0	and/or CC 0	diabetes_mellitus NN B-noun.attribute	. . 0	. . 0
a1967484.s0	Sulpiride SYM 0	- : 0	induced VBN B-verb.creation	tardive_dystonia NNP B-noun.location	. . 0	. . 0
a3107448.s1	Drug NN B-noun.person	- : 0	induced VBN B-verb.creation	hepatotoxicity NN B-noun.attribute	, , 0	although IN 0	common JJ B-noun.person	, , 0	has VBZ 0	been VBN 0	reported VBN B-verb.communication	only RB B-adv.all	infrequently RB B-adv.all	with IN 0	sulfonylureas NNS B-noun.artifact	. . 0	. . 0
a347884.s10	No DT 0	differences NNS B-noun.person	were VBD 0	observed VBN B-verb.perception	with IN 0	respect NN B-noun.act	to TO 0	side VB B-verb.creation	effects NNS B-noun.phenomenon	and CC 0	general JJ B-noun.body	tolerability NN I-noun.body	. . 0	. . 0
a17639754.s4	We PRP 0	report VBP B-verb.stative	3 CD B-adj.all	cases NNS B-noun.quantity	of IN 0	serious JJ B-adj.all	bleeding NN B-noun.communication	complications NNS B-noun.communication	that WDT 0	appear VBP B-verb.change	to TO 0	be VB B-verb.stative	the DT 0	result NN B-noun.act	of IN 0	the DT 0	interaction NN B-noun.act	between IN 0	warfarin NN B-noun.location	and CC 0	levofloxacin NN B-noun.state	. . 0	. . 0
a6747681.s5	In IN 0	the DT 0	nine CD B-adj.all	responders NNS B-noun.person	, , 0	median JJ B-adj.all	duration NN B-noun.act	of IN 0	chemotherapy NN B-noun.communication	response NN B-noun.communication	from IN 0	the DT 0	time NN B-noun.time	of IN 0	operation NN B-noun.person	was VBD B-verb.stative	25 CD B-adj.all	weeks NNS B-noun.time	( ( 0	range VB B-verb.stative	12 CD B-adj.all	to TO 0	more JJR B-noun.quantity	than IN 0	91 CD 0	weeks NNS B-noun.time	) ) 0	. . 0	. . 0
a11745184.s17	Seven CD 0	different JJ B-adj.all	life NN B-noun.person	- : 0	threatening JJ B-verb.communication	toxicities NNS B-noun.person	were VBD 0	observed VBN B-verb.perception	in IN 0	patients NNS B-noun.person	while IN 0	receiving VBG B-verb.perception	treatment NN B-noun.plant	. . 0	. . 0
